Cyclophosphamide monohydrate has been evaluated in numerous clinical trials spanning Early Phase 1 through Phase 4, encompassing recruiting, active not recruiting, completed, and withdrawn statuses. Supported by academic, governmental, and commercial entities—including the National Cancer Institute, Mansoura University, Tufts Medical Center, and Kite—these studies investigate malignancies like breast, ovarian, non-Hodgkin, and diffuse large B-cell lymphomas, as well as non-oncological conditions such as gout tophus and kidney transplantation. Representative Phase 2 and Phase 3 trials evaluate cell therapy regimens in lymphoma and chemotherapy toxicity prevention in breast cancer.
| NCT Number | Recruitment | Conditions | Sponsor/Collaborators | Start Date | Phases |
|---|---|---|---|---|---|
| NCT04877613 | ACTIVE_NOT_RECRUITING | Metastatic Medullary Thyroid Cancer; Recurrent Thyroid Gland Medullary Carcinoma |
University of Pennsylvania |
2021-08-19 | PHASE1 |
| NCT03935893 | ACTIVE_NOT_RECRUITING | Gastric Cancer; Colorectal Cancer; Pancreatic Cancer; Sarcoma; Mesothelioma; Neuroendocrine Tumors; Squamous Cell Cancer; Merkel Cell Carcinoma; Mismatch Repair Deficiency; Microsatellite Instability |
Udai Kammula |
2019-12-03 | PHASE2 |
| NCT07220187 | NOT_YET_RECRUITING | Richter Syndrome; Transformed Chronic Lymphocytic Leukemia to Diffuse Large B-Cell Lymphoma; Transformed Small Lymphocytic Lymphoma to Diffuse Large B-Cell Lymphoma |
SWOG Cancer Research Network |
2026-08-31 | PHASE3 |
| NCT05463133 | RECRUITING | Chronic Granulomatous Disease |
National Institute of Allergy and Infectious Diseases (NIAID) |
2022-07-08 | PHASE1; PHASE2 |
| NCT05508009 | RECRUITING | SIOD; Cystinosis; FSGS; SLE Nephritis; CKD Stage 4 |
Alice Bertaina |
2023-01-10 | PHASE1; PHASE2 |
| NCT06205290 | WITHDRAWN | Leukemia, Lymphocytic, Chronic, B-Cell |
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company |
2024-01-16 | PHASE3 |
| NCT07164469 | NOT_YET_RECRUITING | Large B-cell Lymphoma; Hodgkin Lymphoma |
M.D. Anderson Cancer Center |
2026-12-28 | PHASE2 |
| NCT07662928 | NOT_YET_RECRUITING | Adult Burkitt Lymphoma |
AIDS Malignancy Consortium |
2026-09-17 | PHASE2 |
| NCT05605899 | ACTIVE_NOT_RECRUITING | High-risk Large B-cell Lymphoma (LBCL) |
Kite, A Gilead Company |
2023-02-10 | PHASE3 |
| NCT07719855 | NOT_YET_RECRUITING | Follicular Lymphoma ( FL) |
Ruijin Hospital |
2026-07 | PHASE3 |
| NCT01356290 | RECRUITING | Medulloblastoma Recurrent; Ependymoma Recurrent; ATRT Recurrent; Rare CNS Tumor Recurrent |
Medical University of Vienna |
2014-04 | PHASE2 |
| NCT07276737 | NOT_YET_RECRUITING | NK T-Cell Lymphoma |
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine |
2025-12-30 | PHASE2 |
| NCT05462613 | RECRUITING | Metastatic Colorectal Cancer |
Centre Hospitalier Universitaire de Besancon |
2023-05-09 | PHASE2; PHASE3 |
| NCT06245889 | RECRUITING | Triple Negative Breast Cancer |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2024-05-01 | PHASE2 |
| NCT05848765 | RECRUITING | Relapsed Follicular Lymphoma; Refractory Follicular Lymphoma |
University of Birmingham |
2023-09-04 | PHASE2 |
| NCT03121001 | RECRUITING | Sickle Cell Disease |
University of Illinois at Chicago |
2017-03-20 | PHASE2 |
| NCT06918431 | RECRUITING | B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative; Lymphoblastic Lymphoma |
City of Hope Medical Center |
2025-10-10 | PHASE2 |
| NCT07463313 | NOT_YET_RECRUITING | Thymoma and Thymic Carcinoma |
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine |
2026-03 | PHASE2; PHASE3 |
| NCT07709715 | NOT_YET_RECRUITING | Light Chain (AL) Amyloidosis |
Nexcella Inc. |
2027-01 | PHASE3 |
| NCT07614061 | RECRUITING | Biliary Tract Neoplasms; Cholangiocarcinoma, Intrahepatic; Cholangiocarcinoma, Extrahepatic; Cholangiocarcinoma, Perihilar; Gallbladder Cancer |
Shanghai Zhongshan Hospital |
2026-05 | PHASE1 |
| NCT06815003 | RECRUITING | Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia; Chronic Myelomonocytic Leukemia; Graft Versus Host Disease; Myelodysplastic Syndrome; Myeloproliferative Neoplasm |
City of Hope Medical Center |
2025-04-18 | PHASE2 |
| NCT07223021 | RECRUITING | B-cell Acute Lymphoblastic Leukemia |
Memorial Sloan Kettering Cancer Center |
2025-10-20 | PHASE3 |
| NCT06680752 | RECRUITING | Acute Myeloid Leukemia, in Relapse; Acute Myeloid Leukemia Refractory; MDS (Myelodysplastic Syndrome) |
ARCE Therapeutics, Inc. |
2025-05-20 | PHASE1; PHASE2 |
| NCT07016399 | RECRUITING | Anatomic Stage II Breast Cancer AJCC v8; Anatomic Stage IIIA Breast Cancer AJCC v8; Triple-Negative Breast Carcinoma |
Vandana Abramson |
2025-09-09 | PHASE2 |
| NCT07588698 | NOT_YET_RECRUITING | Non-Hodgkin's B-cell Lymphoma; Lymphoma Non-Hodgkin; Diffuse Large B-Cell Lymphoma (DLBCL) |
Carrie Ho, MD |
2026-09-15 | PHASE2 |
| NCT06795503 | NOT_YET_RECRUITING | Triple-negative Breast Cancer |
Fudan University |
2025-02 | PHASE3 |
| NCT07102940 | NOT_YET_RECRUITING | Breast Cancer; HER 2 Negative Breast Cancer; HR Positive/HER-2 Negative Breast Cancer; Stage 1-3 |
George Washington University |
2026-09-01 | PHASE2 |
| NCT07758673 | NOT_YET_RECRUITING | Recurrent B Acute Lymphoblastic Leukemia; Recurrent B Lymphoblastic Lymphoma; Refractory B Acute Lymphoblastic Leukemia; Refractory B Lymphoblastic Lymphoma |
City of Hope Medical Center |
2027-04-17 | PHASE1 |
| NCT07668557 | RECRUITING | Acute Myeloid Leukemia (AML) |
iCell Gene Therapeutics |
2026-06-10 | PHASE1 |
| NCT02621021 | RECRUITING | Melanoma |
National Cancer Institute (NCI) |
2015-12-04 | PHASE2 |
| NCT07643103 | NOT_YET_RECRUITING | Ph- Acute Lymphoblastic Leukemia (Ph-ALL) |
Institute of Hematology & Blood Diseases Hospital, China |
2026-06-12 | PHASE2 |
| NCT05625594 | RECRUITING | Central Nervous System Lymphoma |
City of Hope Medical Center |
2023-06-29 | PHASE1 |
| NCT06918015 | NOT_YET_RECRUITING | BTK Inhibitors; Follicular Lymphoma; Immunochemotherapy |
Zhejiang Cancer Hospital |
2025-05-01 | PHASE2 |
| NCT05088356 | ACTIVE_NOT_RECRUITING | Allogeneic Hematopoietic Cell Transplantation (HCT); Advanced Hematologic Malignancies; Acute Leukemia; Chronic Myelogenous Leukemia; Myelodysplastic Syndromes; Myeloproliferative Disorders |
Stanford University |
2021-09-07 | PHASE1 |
| NCT06490562 | NOT_YET_RECRUITING | Acute Graft-versus-host Disease |
Institute of Hematology & Blood Diseases Hospital, China |
2024-07 | |
| NCT05106296 | RECRUITING | Ependymoma; Medulloblastoma; Glioblastoma; Primary Brain Tumor |
Theodore S. Johnson |
2022-02-08 | PHASE1 |
| NCT04931342 | ACTIVE_NOT_RECRUITING | Ovarian Cancer |
Hoffmann-La Roche |
2021-10-07 | PHASE2 |
| NCT06091254 | RECRUITING | Follicular Lymphoma (FL) |
Regeneron Pharmaceuticals |
2023-12-12 | PHASE3 |
| NCT07342738 | NOT_YET_RECRUITING | KRAS G12V; KRAS G12D; Solid Tumor |
Sun Yat-sen University |
2026-02-01 | EARLY_PHASE1 |
| NCT07676175 | NOT_YET_RECRUITING | Previously Untreated Peripheral T-Cell Lymphoma |
BeBetter Med Inc |
2026-07-01 | PHASE2 |
| NCT03670966 | RECRUITING | Acute Lymphoblastic Leukemia in Remission; Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome; Acute Myeloid Leukemia in Remission; Chronic Myelomonocytic Leukemia; Myelodysplastic Syndrome With Excess Blasts; Recurrent Acute Lymphoblastic Leukemia; Recurrent Acute Myeloid Leukemia; Refractory Acute Lymphoblastic Leukemia; Refractory Acute Myeloid Leukemia; Recurrent Mixed Phenotype Acute Leukemia; Refractory Mixed Phenotype Acute Leukemia; Hematopoietic and Lymphoid Cell Neoplasm |
Fred Hutchinson Cancer Center |
2019-07-10 | PHASE1; PHASE2 |
| NCT07101432 | RECRUITING | Head and Neck Cancer |
M.D. Anderson Cancer Center |
2025-12-19 | PHASE1 |
| NCT03719105 | RECRUITING | NK-Cell Lymphoma; NK-Cell Leukemia; Peripheral T Cell Lymphoma |
New York Medical College |
2019-03-01 | EARLY_PHASE1 |
| NCT07131085 | NOT_YET_RECRUITING | MDS; AML |
Anhui Provincial Hospital |
2025-08-15 | PHASE1 |
| NCT04232085 | RECRUITING | Primary Immune Deficiency Disorder; Immune Deficiency Disease; Bone Marrow Failure; Short Telomere Length; Fanconi Anemia; Non Fanconi DNA-DSB Repair Disorder; Hoyeraal-Hreidarsson Syndrome; Dyskeratosis Congenita; Telomere Biology Disorder; Short Telomere Syndrome |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2020-02-12 | PHASE2 |
| NCT03622788 | ACTIVE_NOT_RECRUITING | Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia; Aplastic Anemia; Bone Marrow Failure; Chronic Lymphocytic Leukemia; Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Follicular Lymphoma; Hodgkin Lymphoma; Mantle Cell Lymphoma; Myelodysplastic Syndrome; Myeloproliferative Neoplasm; Non-Hodgkin Lymphoma; Plasma Cell Myeloma |
M.D. Anderson Cancer Center |
2019-08-08 | PHASE1; PHASE2 |
| NCT06142396 | RECRUITING | Multiple Myeloma; Renal Failure |
Augusta University |
2024-11-01 | EARLY_PHASE1 |
| NCT05621668 | ACTIVE_NOT_RECRUITING | Soft Tissue Sarcoma; Bone Sarcoma |
M.D. Anderson Cancer Center |
2023-09-08 | PHASE1 |
| NCT04022239 | RECRUITING | Hematopoietic and Lymphoid System Neoplasm |
M.D. Anderson Cancer Center |
2020-03-13 | PHASE1; PHASE2 |
| NCT07739485 | RECRUITING | Triple -Negative Breast Cancer |
Liu Shu |
2026-07-30 | PHASE1; PHASE2 |
| NCT07024147 | NOT_YET_RECRUITING | B-Cell Non-Hodgkin Lymphoma; Large B Cell Diffuse Lymphoma; Follicular Lymphoma; Marginal Zone B Cell Lymphoma; Mantle Cell Lymphoma (MCL) |
Peking University Cancer Hospital & Institute |
2025-07-01 | PHASE1 |
| NCT06253663 | ACTIVE_NOT_RECRUITING | Relapsed/Refractory Mantle Cell Lymphoma; Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia |
Kite, A Gilead Company |
2024-03-18 | PHASE2 |
| NCT07598955 | RECRUITING | B2 Thymoma; Thymic Carcinoma |
Beijing Biotech |
2026-03-02 | PHASE1; PHASE2 |
| NCT05420454 | RECRUITING | Breast Cancer |
Second Affiliated Hospital, Zhejiang University, School of Medicine |
2022-07-10 | PHASE4 |
| NCT01140373 | ACTIVE_NOT_RECRUITING | Prostate Cancer |
Memorial Sloan Kettering Cancer Center |
2010-06 | PHASE1 |
| NCT04803201 | RECRUITING | Angioimmunoblastic T-cell Lymphoma; Enteropathy-Associated T-Cell Lymphoma; Follicular T-Cell Lymphoma; Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma; Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma; Nodal Peripheral T-Cell Lymphoma With TFH Phenotype; Peripheral T-Cell Lymphoma, Not Otherwise Specified |
Alliance for Clinical Trials in Oncology |
2021-10-08 | PHASE2 |
| NCT06939270 | NOT_YET_RECRUITING | Solid Tumor |
Chinese PLA General Hospital |
2025-05-01 | PHASE1; PHASE2 |
| NCT01860937 | ACTIVE_NOT_RECRUITING | Relapsed B-Cell Acute Lymphoblastic Leukemia |
Memorial Sloan Kettering Cancer Center |
2013-05 | PHASE1 |
| NCT05999994 | RECRUITING | Neoplasms; Child; Adolescent |
Eli Lilly and Company |
2020-01-22 | PHASE2 |
| NCT07551336 | RECRUITING | Malignant Glioma; High-Grade Gliomas; Glioblastoma; Recurrent High-Grade Gliomas; Recurrent Glioblastoma |
Beijing Biotech |
2026-03-02 | PHASE1 |
| NCT04859946 | ACTIVE_NOT_RECRUITING | Hematologic and Lymphocytic Disorder |
M.D. Anderson Cancer Center |
2022-01-11 | PHASE2 |
| NCT06898385 | RECRUITING | Pancreatic Cancer |
Sun Yat-sen University |
2025-03-27 | PHASE1 |
| NCT04897321 | RECRUITING | Pediatric Solid Tumor; Osteosarcoma; Rhabdomyosarcoma; Neuroblastoma; Ewing Sarcoma; Wilms Tumor; Adrenocortical Cancer; Desmoplastic Small Round Cell Tumor; Germ Cell Cancer; Rhabdoid Tumor; Clear Cell Sarcoma; Hepatoblastoma; Melanoma; Carcinoma; Malignant Peripheral Nerve Sheath Tumors; Soft Tissue Sarcoma |
St. Jude Children's Research Hospital |
2022-07-06 | PHASE1 |
| NCT04510051 | RECRUITING | Malignant Brain Neoplasm; Recurrent Malignant Brain Neoplasm; Refractory Malignant Brain Neoplasm |
City of Hope Medical Center |
2020-12-04 | PHASE1 |
| NCT05075993 | ACTIVE_NOT_RECRUITING | Metastatic Esophageal; Gastric Cancer; Metastatic Head and Neck Carcinoma; Metastatic Hepatocellular Carcinoma; Metastatic HPV Related Solid Tumors; Metastatic Ovarian Carcinoma; Metastatic Soft Tissue Sarcoma; Metastatic Uveal Melanoma |
M.D. Anderson Cancer Center |
2021-11-12 | PHASE1 |
| NCT06152172 | ACTIVE_NOT_RECRUITING | Idiopathic Inflammatory Myopathies; Diffuse Cutaneous Systemic Sclerosis; SLE Nephritis; ANCA Associated Vasculitis |
David Porter |
2024-08-05 | PHASE1 |
| NCT04978584 | ACTIVE_NOT_RECRUITING | Diffuse Large B-Cell Lymphoma |
M.D. Anderson Cancer Center |
2022-03-03 | PHASE2 |
| NCT04540380 | ACTIVE_NOT_RECRUITING | Renal Failure |
Massachusetts General Hospital |
2021-09-01 | PHASE1 |
| NCT01804634 | RECRUITING | Refractory and/or Relapsed Metastatic Solid Tumors |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2013-03-27 | PHASE2 |
| NCT04792489 | RECRUITING | Refractory Diffuse Large B Cell Lymphoma (DLBCL); Relapsed Diffuse Large B Cell Lymphoma; High Grade B-cell Lymphoma (HGBCL); Primary Mediastinal B-cell Lymphoma (PMBCL); Transformed Lymphoma; Central Nervous System Lymphoma; Mantle Cell Lymphoma (MCL); Richter Transformation; Transplant-ineligible 2nd Line DLBCL |
Miltenyi Biomedicine GmbH |
2021-05-25 | PHASE2 |
| NCT02981628 | ACTIVE_NOT_RECRUITING | Recurrent B Acute Lymphoblastic Leukemia; Recurrent B Lymphoblastic Lymphoma; Refractory B Acute Lymphoblastic Leukemia; Refractory B Lymphoblastic Lymphoma |
Children's Oncology Group |
2017-06-19 | PHASE2 |
| NCT05400122 | SUSPENDED | Colorectal Cancer; Hematologic Malignancy; Rectum Cancer; Acute Myeloid Leukemia; Myelodysplastic Syndromes; Acute Lymphoblastic Leukemia; Chronic Myeloid Leukemia; Chronic Lymphocytic Leukemia; Hodgkin Lymphoma; Non Hodgkin Lymphoma; Myeloproliferative Syndrome; Plasma Cell Myeloma; Gastric Cancer; Esophageal Cancer; Esophagus Cancer; Gastric Cancer, Metastatic; Unresectable Esophageal Cancer; Metastatic Esophageal Cancer |
David Wald |
2022-09-09 | PHASE1 |
| NCT04638790 | RECRUITING | Hodgkin Lymphoma, Adult |
State Budgetary Healthcare Institution, National Medical Surgical Center N.A. N.I. Pirogov, Ministry of Health of Russia |
2020-02-01 | PHASE3 |
| NCT07635342 | RECRUITING | HER2-positive Breast Cancer |
Hebei Medical University Fourth Hospital |
2024-04-30 | PHASE2 |
| NCT06499025 | ENROLLING_BY_INVITATION | AML; t(8;21); Neoantigen |
BGI, China |
2024-02-01 | EARLY_PHASE1 |
| NCT07716176 | RECRUITING | Nausea and Vomiting Caused by Chemotherapy |
Second Affiliated Hospital, Zhejiang University, School of Medicine |
2025-12-12 | PHASE3 |
| NCT01746849 | ACTIVE_NOT_RECRUITING | Leukemia; Multiple Myeloma; Myelodysplastic Syndrome; Non-Hodgkin's Lymphoma |
Memorial Sloan Kettering Cancer Center |
2012-12 | PHASE2 |
| NCT06773091 | RECRUITING | Advanced Solid Tumors |
Shanghai NK Cell Technology Co., LTD |
2025-02-07 | PHASE1 |
| NCT02143830 | RECRUITING | Fanconi Anemia; Severe Marrow Failure; Myelodysplastic Syndrome (MDS); Acute Myelogenous Leukemia (AML) |
Children's Hospital Medical Center, Cincinnati |
2014-04 | PHASE2 |
| NCT02877303 | RECRUITING | B Acute Lymphoblastic Leukemia; B Lymphoblastic Lymphoma |
M.D. Anderson Cancer Center |
2016-11-01 | PHASE2 |
| NCT01176006 | ACTIVE_NOT_RECRUITING | DOCK8 Deficiency |
National Cancer Institute (NCI) |
2010-10-05 | PHASE2 |
| NCT07077486 | RECRUITING | Lupus or SLE; Interstitial Lung Disease; Systemic Lupus Erythematosus |
Tongji Hospital |
2025-08-25 | PHASE4 |
| NCT06977711 | RECRUITING | Diffuse Large B-cell Lymphoma |
The University of Texas Health Science Center at San Antonio |
2025-06-20 | PHASE1 |
| NCT02451982 | ACTIVE_NOT_RECRUITING | Pancreatic Cancer |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2016-03-28 | PHASE2 |
| NCT06210750 | WITHDRAWN | T Acute Lymphoblastic Leukemia; T Lymphoblastic Lymphoma |
National Cancer Institute (NCI) |
2024-08-09 | PHASE2 |
| NCT03467386 | SUSPENDED | Acute Myeloid Leukemia |
City of Hope Medical Center |
2018-03-19 | PHASE1 |
| NCT05498896 | ACTIVE_NOT_RECRUITING | Triple Negative Breast Cancer |
Queen Mary University of London |
2018-12-19 | PHASE2 |
| NCT04904588 | ACTIVE_NOT_RECRUITING | Acute Lymphoblastic Leukemia; Acute Myelogenous Leukemia; Mixed Phenotype Acute Leukemia; Acute Leukemia; Myelodysplastic Syndromes; Chronic Myelogenous Leukemia; Chronic Lymphocytic Leukemia; Lymphoma |
Center for International Blood and Marrow Transplant Research |
2021-09-30 | PHASE2 |
| NCT05582590 | NOT_YET_RECRUITING | Oropharyngeal Cancer; Human Papilloma Virus; Head and Neck Cancer; Head and Neck Squamous Cell Carcinoma; Oropharyngeal Squamous Cell Carcinoma; Oropharyngeal Cancer, Metastatic; Head and Neck Cancer Metastatic; HPV-Related Squamous Cell Carcinoma; HPV-Related Mucosal Head and Neck Squamous Cell Carcinoma; Relapsed Oropharyngeal SCC; Refractory Oropharyngeal Squamous Cell Carcinoma |
NexImmune Inc. |
2025-03-31 | PHASE1 |
| NCT04994132 | ACTIVE_NOT_RECRUITING | Alveolar Rhabdomyosarcoma; Botryoid-Type Embryonal Rhabdomyosarcoma; Embryonal Rhabdomyosarcoma; Metastatic Embryonal Rhabdomyosarcoma; Metastatic Rhabdomyosarcoma; Solid Alveolar Rhabdomyosarcoma; Spindle Cell Rhabdomyosarcoma; Spindle Cell/Sclerosing Rhabdomyosarcoma |
Children's Oncology Group |
2021-09-14 | PHASE3 |
| NCT04850495 | ACTIVE_NOT_RECRUITING | Diffuse Large B-Cell Lymphoma; Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma; Transformed Marginal Zone Lymphoma to Diffuse Large B-Cell Lymphoma |
Yazeed Sawalha |
2021-11-16 | PHASE1 |
| NCT05934097 | WITHDRAWN | Diffuse Large B Cell Lymphoma; Transformed Indolent Non-Hodgkin's Lymphoma; Follicular Lymphoma; Mantle Cell Lymphoma; Marginal Zone Lymphoma |
Fate Therapeutics |
2022-12 | PHASE1 |
| NCT05453500 | ACTIVE_NOT_RECRUITING | B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative |
University of Washington |
2023-03-27 | PHASE2 |
| NCT04872985 | ACTIVE_NOT_RECRUITING | Breast Cancer; Hormone-receptor Positive Breast Cancer |
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University |
2021-04-20 | PHASE2 |
| NCT03420963 | TERMINATED | Recurrent Cutaneous Melanoma; Recurrent Lip and Oral Cavity Carcinoma; Recurrent Malignant Endocrine Neoplasm; Recurrent Malignant Female Reproductive System Neoplasm; Recurrent Malignant Male Reproductive System Neoplasm; Recurrent Malignant Mesothelioma; Recurrent Malignant Neoplasm of Multiple Primary Sites; Recurrent Malignant Oral Neoplasm; Recurrent Malignant Pharyngeal Neoplasm; Recurrent Malignant Skin Neoplasm; Recurrent Malignant Soft Tissue Neoplasm; Recurrent Malignant Solid Neoplasm; Recurrent Malignant Thyroid Gland Neoplasm; Recurrent Malignant Urinary System Neoplasm; Refractory Cutaneous Melanoma; Refractory Malignant Bone Neoplasm; Refractory Malignant Endocrine Neoplasm; Refractory Malignant Female Reproductive System Neoplasm; Refractory Malignant Male Reproductive System Neoplasm; Refractory Malignant Mesothelioma; Refractory Malignant Neoplasm of Multiple Primary Sites; Refractory Malignant Oral Neoplasm; Refractory Malignant Pharyngeal Neoplasm; Refractory Malignant Skin Neoplasm; Refractory Malignant Soft Tissue Neoplasm; Refractory Malignant Solid Neoplasm; Refractory Malignant Thyroid Gland Neoplasm; Refractory Malignant Urinary System Neoplasm |
M.D. Anderson Cancer Center |
2018-08-31 | PHASE1 |
| NCT04803058 | TERMINATED | Kidney Transplantation |
ITB-Med LLC |
2022-12-14 | PHASE2 |
| NCT05040568 | COMPLETED | Colon Cancer; Resected Stage |
M.D. Anderson Cancer Center |
2022-02-28 | PHASE1 |
| NCT06607016 | ACTIVE_NOT_RECRUITING | Anti-Glomerular Basement Membrane Disease |
Shanghai Bao Pharmaceuticals Co., Ltd. |
2024-10-21 | PHASE2 |
| NCT06302062 | RECRUITING | Advanced Solid Tumor; Tumor Associated Lymph Node T Cell; Immunotherapy |
Guangzhou FineImmune Biotechnology Co., LTD. |
2023-06-06 | PHASE1 |
| NCT06119685 | RECRUITING | NHL; Multiple Myeloma; Blood Cancer; Refractory Non-Hodgkin Lymphoma; Relapsed Non-Hodgkin Lymphoma; Refractory Multiple Myeloma; Relapsed Multiple Myeloma |
Indapta Therapeutics, INC. |
2023-10-25 | PHASE1; PHASE2 |
| NCT06656962 | ACTIVE_NOT_RECRUITING | Antineutrophil Cytoplasmic Antibody (ANCA)-associated Nephritis (AAGN) |
Renmin Hospital of Wuhan University |
2024-10-10 | PHASE1; PHASE2 |
| NCT06696833 | RECRUITING | B-Cell Acute Lymphoblastic Leukemia, Adult |
The First Affiliated Hospital of Soochow University |
2024-12-01 | EARLY_PHASE1 |
| NCT06145282 | ACTIVE_NOT_RECRUITING | Sickle Cell Disease |
National Heart, Lung, and Blood Institute (NHLBI) |
2023-12-28 | PHASE1; PHASE2 |
| NCT05907746 | ACTIVE_NOT_RECRUITING | GATA2; Immunodeficiency |
National Cancer Institute (NCI) |
2023-11-29 | PHASE2 |
| NCT03036488 | COMPLETED | Triple Negative Breast Neoplasms |
Merck Sharp & Dohme LLC |
2017-03-07 | PHASE3 |
| NCT05296317 | COMPLETED | Localized Breast Cancer |
Centre Georges Francois Leclerc |
2022-09-02 | |
| NCT04074746 | COMPLETED | Recurrent Anaplastic Large Cell Lymphoma; Recurrent B-Cell Non-Hodgkin Lymphoma; Recurrent Classic Hodgkin Lymphoma; Recurrent Mycosis Fungoides; Recurrent Peripheral T-Cell Lymphoma, Not Otherwise Specified; Refractory Anaplastic Large Cell Lymphoma; Refractory B-Cell Non-Hodgkin Lymphoma; Refractory Classic Hodgkin Lymphoma; Refractory Mycosis Fungoides; Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified |
M.D. Anderson Cancer Center |
2020-07-18 | PHASE1; PHASE2 |
| NCT06532643 | RECRUITING | Relapsed/Refractory Lymphoma |
Shanghai First Song Biotechnology Co., LTD |
2023-08-24 | EARLY_PHASE1 |
| NCT03696784 | ACTIVE_NOT_RECRUITING | Lymphoma; Lymphoma, B-Cell; Immune System Diseases; Immunoproliferative Disorders; Lymphatic Diseases |
UNC Lineberger Comprehensive Cancer Center |
2019-03-12 | PHASE1 |
| NCT05510323 | RECRUITING | Glomerulonephritis, IGA |
Air Force Military Medical University, China |
2024-02-01 | PHASE3 |
| NCT05422066 | UNKNOWN | DLBCL Germinal Center B-Cell Type |
Li Zhiming |
2022-07-26 | PHASE2 |
| NCT05768035 | UNKNOWN | Hematological Malignancies |
Smart Immune SAS |
2023-06-06 | PHASE1; PHASE2 |
| NCT05051891 | COMPLETED | Treatment-naїve Mantle Cell Lymphoma |
Beijing InnoCare Pharma Tech Co., Ltd. |
2021-12-22 | PHASE3 |
| NCT06224049 | UNKNOWN | T-cell Lymphoma |
BGI, China |
2023-12-01 | EARLY_PHASE1 |
| NCT06255847 | UNKNOWN | Multiple Myeloma in Relapse |
Shanxi Bethune Hospital |
2022-06-15 | PHASE2 |
| NCT04697940 | ACTIVE_NOT_RECRUITING | Relapsed and Refractory B-cell Non-Hodgkin's Lymphoma; Decitabine-primed Tandem CD19/CD20 CAR T Cells |
Han weidong |
2021-04-15 | PHASE1; PHASE2 |
| NCT04504825 | ACTIVE_NOT_RECRUITING | AL Amyloidosis |
Alexion Pharmaceuticals, Inc. |
2020-08-25 | PHASE3 |
| NCT03663933 | ACTIVE_NOT_RECRUITING | Lymphoproliferative Disorders; Autoimmune Lymphoproliferative; Primary T-cell Immunodeficiency Disorders; Immune System Diseases; Common Variable Immunodeficiency |
National Cancer Institute (NCI) |
2018-09-04 | PHASE2 |
| NCT03942887 | UNKNOWN | ANCA Associated Vasculitis |
Leiden University Medical Center |
2019-05-03 | PHASE3 |
| NCT05201248 | ACTIVE_NOT_RECRUITING | B-Cell Non-Hodgkin Lymphoma |
Genmab |
2022-03-10 | PHASE1; PHASE2 |
| NCT05780554 | UNKNOWN | Graft Vs Host Disease |
Centro de Hematología y Medicina Interna |
2023-03-10 | |
| NCT05238064 | UNKNOWN | PI3Kδ Inhibitor; Parsaclisib; CHOP; PTCL |
Fudan University |
2022-03 | PHASE1; PHASE2 |
| NCT05442580 | TERMINATED | Acute Myeloid Leukemia (AML); Multiple Myeloma (MM) |
University of Pennsylvania |
2023-05-30 | PHASE1 |
| NCT05640713 | UNKNOWN | Allogeneic, CAR-T, Protein Sequestration, Non-gene Edited |
Henan Cancer Hospital |
2022-12-01 | PHASE1 |
| NCT05787535 | UNKNOWN | Cervical Cancer; Head and Neck Squamous Cell Carcinoma; Oropharyngeal Cancer; Vagina Tumor; Carcinoma of Penis; Anal Carcinoma; Carcinoma of Vulva |
HRYZ Biotech Co. |
2023-03-21 | PHASE1 |
| NCT04432714 | RECRUITING | DLBCL; Untreated; MYC Gene Rearrangement |
The First Affiliated Hospital with Nanjing Medical University |
2020-06-09 | PHASE1; PHASE2 |
| NCT05517213 | COMPLETED | Multiple Myeloma |
Affiliated Hospital to Academy of Military Medical Sciences |
2022-09-01 | |
| NCT05458180 | UNKNOWN | Peripheral T-cell Lymphoma |
Tianjin Medical University Cancer Institute and Hospital |
2022-07-07 | PHASE1 |
| NCT03220022 | ACTIVE_NOT_RECRUITING | AIDS-Related Lymphoma; Ann Arbor Stage II Diffuse Large B-Cell Lymphoma; Ann Arbor Stage III Diffuse Large B-Cell Lymphoma; Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma |
National Cancer Institute (NCI) |
2018-03-16 | PHASE1 |
| NCT05032820 | COMPLETED | Multiple Myeloma |
Medical College of Wisconsin |
2022-01-05 | PHASE2 |
| NCT03107988 | COMPLETED | Neuroblastoma |
New Approaches to Neuroblastoma Therapy Consortium |
2017-09-05 | PHASE1 |
| NCT03610490 | TERMINATED | Malignant Solid Neoplasm; Metastatic Colorectal Adenocarcinoma; Metastatic Ovarian Carcinoma; Metastatic Pancreatic Ductal Adenocarcinoma; Platinum-Resistant Ovarian Carcinoma; Recurrent High Grade Ovarian Serous Adenocarcinoma; Recurrent Ovarian Carcinosarcoma; Refractory Colorectal Carcinoma; Stage IV Colorectal Cancer AJCC v8; Stage IVA Colorectal Cancer AJCC v8; Stage IVB Colorectal Cancer AJCC v8; Stage IVC Colorectal Cancer AJCC v8 |
M.D. Anderson Cancer Center |
2018-10-16 | PHASE2 |
| NCT05515029 | ACTIVE_NOT_RECRUITING | Acute Lymphoblastic Leukemia; Myeloblastic Leukemia; Biphenotypic Acute Leukemia; Malignant Lymphoma; Myelodysplastic Syndromes; Juvenile Myelomonocytic Leukemia |
Federal Research Institute of Pediatric Hematology, Oncology and Immunology |
2022-08-23 | PHASE3 |
| NCT00878254 | COMPLETED | Mantle-Cell Lymphoma |
University of Miami |
2009-03-25 | PHASE2 |
| NCT04656262 | TERMINATED | Soft Tissue Sarcoma Adult |
Istituto Oncologico Veneto IRCCS |
2018-09-10 | PHASE3 |
| NCT05872412 | UNKNOWN | Triple Negative Breast Cancer |
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh |
2023-06-01 | PHASE2 |
| NCT06703346 | COMPLETED | Neoplasms |
USWM CT, LLC |
2019-12-31 | PHASE2 |
| NCT03967223 | ACTIVE_NOT_RECRUITING | Neoplasms |
USWM CT, LLC |
2019-12-31 | PHASE2 |
| NCT02950051 | COMPLETED | Chronic Lymphocytic Leukemia |
German CLL Study Group |
2016-12-13 | PHASE3 |
| NCT02566304 | COMPLETED | Acute Myeloid Leukemia; Acute Myeloid Leukemia in Remission; Aplastic Anemia; Chronic Myelomonocytic Leukemia; Hodgkin Lymphoma; Indolent Non-Hodgkin Lymphoma; Malignant Neoplasm; Myelodysplastic Syndrome; Myeloproliferative Neoplasm; Plasma Cell Myeloma; Refractory Anemia; Refractory Anemia With Excess Blasts; Refractory Anemia With Ring Sideroblasts; Refractory Cytopenia With Multilineage Dysplasia; Refractory Cytopenia With Multilineage Dysplasia and Ring Sideroblasts |
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University |
2015-11-13 | PHASE2 |
| NCT00390793 | COMPLETED | Acute Lymphoblastic Leukemia; BCR-ABL1 Fusion Protein Expression; Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Philadelphia Chromosome Positive; Recurrent Acute Lymphoblastic Leukemia; t(9;22) |
M.D. Anderson Cancer Center |
2006-09-28 | PHASE2 |
| NCT03836352 | ACTIVE_NOT_RECRUITING | Ovarian Cancer; Hepatocellular Carcinoma; Non-small Cell Lung Cancer; Bladder Cancer; Microsatellite Instability-High |
ImmunoVaccine Technologies, Inc. (IMV Inc.) |
2018-12-21 | PHASE2 |
| NCT04214626 | COMPLETED | Diffuse Large B Cell Lymphoma |
Henan Cancer Hospital |
2020-01-05 | PHASE2 |
| NCT04825496 | UNKNOWN | Relapsed or Refractory Acute Lymphoblastic Leukemia |
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd |
2021-04-09 | PHASE1 |
| NCT01374841 | UNKNOWN | Hematologic Neoplasms |
European Institute of Oncology |
2010-08 | PHASE2 |
| NCT06186700 | Active not recruiting | Breast Cancer Female |
Mansoura University |
2023-12-25 | Phase 2 |
| NCT06085742 | Recruiting | Breast Cancer |
University of Illinois at Chicago |
2023-11-22 | Phase 2 |
| NCT04665076 | UNKNOWN | Plasma Cell Tumors |
Hebei Senlang Biotechnology Inc., Ltd. |
2020-10-22 | |
| NCT01595321 | COMPLETED | Pancreatic Cancer |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2012-10-29 | PHASE2 |
| NCT05000450 | TERMINATED | Relapsed/Refractory Multiple Myeloma |
Allogene Therapeutics |
2021-06-06 | PHASE1; PHASE2 |
| NCT05165225 | ACTIVE_NOT_RECRUITING | Breast Cancer; HER2-low-expressing Breast Cancer; Hormone Receptor-positive Breast Cancer; Neoadjuvant Therapy |
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University |
2021-07-13 | PHASE2 |
| NCT02626455 | TERMINATED | Lymphoma, Non-Hodgkin |
Bayer |
2016-01-06 | PHASE3 |
| NCT01413100 | COMPLETED | Systemic Scleroderma |
Fred Hutchinson Cancer Center |
2011-09-15 | PHASE2 |
| NCT04551885 | TERMINATED | Solid Tumor, Adult |
Fate Therapeutics |
2020-09-07 | PHASE1 |
| NCT04770272 | TERMINATED | Triple-negative Breast Cancer |
Palleos Healthcare GmbH |
2021-03-01 | PHASE2 |
| NCT04941885 | UNKNOWN | Breast Cancer |
Sun Yat-sen University |
2021-06-25 | PHASE2 |
| NCT04109482 | TERMINATED | Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) |
Mustang Bio |
2020-02-17 | PHASE1; PHASE2 |
| NCT04038489 | WITHDRAWN | Breast Cancer; Estrogen Receptor-positive Breast Cancer |
University of Virginia |
2019-10-18 | PHASE2 |
| NCT04480099 | UNKNOWN | Peripheral T-cell Lymphoma |
Ruijin Hospital |
2020-07-29 | PHASE2 |
| NCT04632316 | UNKNOWN | Acute Myeloid Leukemia |
Glycostem Therapeutics BV |
2020-12-08 | PHASE1; PHASE2 |
| NCT05800041 | Not yet recruiting | Gout Tophus |
RenJi Hospital|Westlake Therapeutics |
2023-04-10 | Early Phase 1 |
| NCT04626752 | UNKNOWN | Relapsed or Refractory Multiple Myeloma |
Hebei Senlang Biotechnology Inc., Ltd. |
2020-04-01 | EARLY_PHASE1 |
| NCT00003927 | COMPLETED | Breast Cancer |
City of Hope Medical Center |
1999-05-18 | PHASE1 |
| NCT04842318 | UNKNOWN | Follicular Lymphoma |
Ruijin Hospital |
2021-03-01 | PHASE4 |
| NCT02960646 | COMPLETED | Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia; Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome; Aplastic Anemia; Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Chronic Myelomonocytic Leukemia; Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive; Lymphoblastic Lymphoma; Myelodysplastic Syndrome; Myeloproliferative Neoplasm; Plasma Cell Myeloma; Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma; Recurrent Hodgkin Lymphoma; Recurrent Non-Hodgkin Lymphoma; Recurrent Plasma Cell Myeloma; Therapy-Related Myelodysplastic Syndrome |
M.D. Anderson Cancer Center |
2017-01-18 | PHASE1 |
| NCT03184194 | COMPLETED | Myeloma |
Amsterdam UMC, location VUmc |
2018-02-21 | PHASE2 |
| NCT04418219 | WITHDRAWN | Anatomic Stage IV Breast Cancer AJCC v8; Metastatic Breast Carcinoma; Prognostic Stage IV Breast Cancer AJCC v8; Recurrent Breast Carcinoma; Refractory Breast Carcinoma |
Thomas Jefferson University |
2020-12-21 | PHASE1; PHASE2 |
| NCT03450122 | COMPLETED | HLA-A*0201 Positive Cells Present; NY-ESO-1 Positive Tumor Cells Present; Recurrent Myxoid Liposarcoma; Recurrent Synovial Sarcoma |
M.D. Anderson Cancer Center |
2018-09-13 | PHASE1 |
| NCT03700450 | COMPLETED | Multiple Myeloma |
Universitätsklinikum Hamburg-Eppendorf |
2018-03-16 | PHASE2 |
| NCT04258683 | WITHDRAWN | Multiple Myeloma |
Canadian Myeloma Research Group |
2021-02-17 | PHASE2 |
| NCT02636322 | COMPLETED | Diffuse Large B-Cell Lymphoma Unclassifiable |
M.D. Anderson Cancer Center |
2016-03-29 | PHASE2 |
| NCT05943990 | TERMINATED | Neoplasms |
Adaptimmune |
2020-12-21 | PHASE1 |
| NCT04927884 | TERMINATED | Advanced Triple Negative Breast Cancer |
ImmunityBio, Inc. |
2021-09-08 | PHASE1; PHASE2 |
| NCT03697824 | WITHDRAWN | Neoplasms |
GlaxoSmithKline |
2019-02-25 | PHASE2 |
| NCT03215524 | COMPLETED | Multiple Myeloma |
Canadian Myeloma Research Group |
2017-10-25 | PHASE2 |
| NCT03808480 | UNKNOWN | Non-small Cell Lung Cancer |
National Cancer Center, Korea |
2019-01-23 | PHASE2 |
| NCT04660799 | COMPLETED | Lymphoma, Large B-Cell, Diffuse |
Hoffmann-La Roche |
2021-02-24 | PHASE2 |
| NCT03935347 | WITHDRAWN | Metastatic Bladder Urothelial Carcinoma; Metastatic Renal Pelvis Urothelial Carcinoma; Metastatic Ureter Urothelial Carcinoma; Metastatic Urethral Urothelial Carcinoma; Unresectable Renal Pelvis Urothelial Carcinoma; Unresectable Ureter Urothelial Carcinoma |
Roswell Park Cancer Institute |
2019-06-20 | PHASE2 |
| NCT02844322 | COMPLETED | Waldenström Macroglobulinemia |
Institute of Hematology & Blood Diseases Hospital, China |
2016-05 | PHASE4 |
| NCT04317248 | UNKNOWN | Hepatocellular Carcinoma |
Yuehua Huang |
2020-04-01 | PHASE2 |
| NCT02461888 | COMPLETED | Multiple Myeloma |
University of Leeds |
2015-12 | PHASE2 |
| NCT03153410 | COMPLETED | Pancreatic Cancer |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2018-09-27 | EARLY_PHASE1 |
| NCT02513186 | COMPLETED | Plasma Cell Myeloma |
Sanofi |
2015-09-30 | PHASE1 |
| NCT02248597 | COMPLETED | Graft Versus Host Disease; Hematopoietic/Lymphoid Cancer |
Wake Forest University Health Sciences |
2015-02-25 | PHASE2 |
| NCT01554852 | UNKNOWN | Multiple Myeloma |
University of Leeds |
2010-05 | PHASE3 |
| NCT02954055 | COMPLETED | Breast Cancer |
ETOP IBCSG Partners Foundation |
2017-09-13 | PHASE2 |
| NCT02999854 | TERMINATED | Acute Myeloid Leukemia; Acute Lymphoblastic Leukemia; Myelodysplastic Syndrome |
Kiadis Pharma |
2017-11-29 | PHASE3 |
| NCT01019876 | COMPLETED | Bone Marrow Failure; Osteopetrosis; Fanconi Anemia; Severe Combined Immunodeficiency |
Columbia University |
2002-09 | PHASE2; PHASE3 |
| NCT01779050 | TERMINATED | Breast Neoplasms |
Washington University School of Medicine |
2013-12-19 | PHASE2 |
| NCT02918747 | UNKNOWN | Lymphoma |
Hunan Cancer Hospital |
2016-09 | PHASE2 |
| NCT01091831 | COMPLETED | Multiple Myeloma |
Fondazione EMN Italy Onlus |
2009-07 | PHASE3 |
| NCT02918292 | COMPLETED | Severe Aplastic Anemia |
Medical College of Wisconsin |
2017-07-03 | PHASE2 |
| NCT03492255 | TERMINATED | Systemic Lupus Erythematosus (SLE) |
University of Sao Paulo General Hospital |
2018-04-12 | |
| NCT03564704 | UNKNOWN | Leukemia; Leukemia, Acute; Adult Lymphoblastic Lymphoma; Leukemia, Lymphoblastic; Leukemia, T Cell; Adult Acute Lymphoblastic Leukemia; Lymphoblastic Lymphoma; Lymphoblastic Leukemia |
Nanfang Hospital, Southern Medical University |
2016-02-14 | PHASE2; PHASE3 |
| NCT03579888 | TERMINATED | B Acute Lymphoblastic Leukemia With t(v;11q23.3); KMT2A Rearranged; Recurrent B Acute Lymphoblastic Leukemia; Recurrent Chronic Lymphocytic Leukemia; Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified; Recurrent Mantle Cell Lymphoma; Recurrent Non-Hodgkin Lymphoma; Recurrent Ph-Like Acute Lymphoblastic Leukemia; Recurrent Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma; Recurrent Small Lymphocytic Lymphoma; Refractory B Acute Lymphoblastic Leukemia; Refractory Chronic Lymphocytic Leukemia; Refractory Diffuse Large B-Cell Lymphoma, Not Otherwise Specified; Refractory Mantle Cell Lymphoma; Refractory Non-Hodgkin Lymphoma; Refractory Ph-Like Acute Lymphoblastic Leukemia; Refractory Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma; Refractory Small Lymphocytic Lymphoma |
M.D. Anderson Cancer Center |
2020-06-26 | PHASE1 |
| NCT04205240 | TERMINATED | Recurrent Plasma Cell Myeloma |
Srinivas Devarakonda |
2020-12-22 | PHASE2 |
| NCT03338972 | COMPLETED | Recurrent Plasma Cell Myeloma; Refractory Plasma Cell Myeloma |
Fred Hutchinson Cancer Center |
2017-11-29 | PHASE1 |
| NCT04361058 | WITHDRAWN | Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Myelodysplastic Syndrome Acute Myeloid Leukemia |
SCRI Development Innovations, LLC |
2020-04-13 | PHASE1 |
| NCT03391466 | COMPLETED | Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL) |
Kite, A Gilead Company |
2018-01-25 | PHASE3 |
| NCT02096614 | COMPLETED | Solid Tumors |
Mie University |
2014-04 | PHASE1 |
| NCT03527628 | UNKNOWN | Classical Hodgkin Lymphoma; Hodgkin Lymphoma (Category); Hodgkin Disease; Hodgkin Lymphoma |
King Abdullah International Medical Research Center |
2018-01-01 | PHASE2 |
| NCT03892330 | NOT_YET_RECRUITING | 0.5-14 Year Old Children With Nephroblastoma |
Shengjing Hospital |
2019-06-01 | PHASE4 |
| NCT03385096 | UNKNOWN | Autologous Hematopoietic Stem Cell Transplantation; Conditioning; Multiple Myeloma |
Nanfang Hospital, Southern Medical University |
2018-01-02 | PHASE2; PHASE3 |
| NCT02936375 | UNKNOWN | Lupus Nephritis |
RenJi Hospital |
2017-09-07 | PHASE2 |
| NCT03908528 | COMPLETED | Breast Cancer; Chemotherapeutic Toxicity |
Damanhour University |
2019-03-01 | |
| NCT02025881 | TERMINATED | High-risk Medulloblastoma |
Gustave Roussy, Cancer Campus, Grand Paris |
2013-09-14 | PHASE1; PHASE2 |
| NCT02807103 | COMPLETED | Eosinophilic Granulomatosis With Polyangiitis (EGPA) |
Assistance Publique - Hôpitaux de Paris |
2016-12-05 | PHASE3 |
| NCT00352976 | COMPLETED | Fanconi Anemia |
Masonic Cancer Center, University of Minnesota |
2006-05-18 | PHASE2; PHASE3 |
| NCT02785250 | UNKNOWN | Recurrent Epithelial Ovarian Cancer; Recurrent Fallopian Tube Cancer; Recurrent Peritoneal Cancer |
ImmunoVaccine Technologies, Inc. (IMV Inc.) |
2016-04 | PHASE1; PHASE2 |
| NCT03617432 | UNKNOWN | Experimental Tumor |
Peking University |
2018-08-28 | PHASE2 |
| NCT03149679 | TERMINATED | Colorectal Cancer Metastatic; Colorectal Cancer Stage IV; TP53 Gene Mutation |
Haukeland University Hospital |
2017-05-09 | PHASE2 |
| NCT02506777 | UNKNOWN | Breast Cancer |
N.N. Petrov National Medical Research Center of Oncology |
2015-07 | PHASE2 |
| NCT02408016 | TERMINATED | Advanced Pleural Malignant Mesothelioma; HLA-A*0201 Positive Cells Present; Recurrent Non-Small Cell Lung Carcinoma; Recurrent Pleural Malignant Mesothelioma; Stage III Non-Small Cell Lung Cancer AJCC v7; Stage III Pleural Malignant Mesothelioma AJCC v7; Stage IIIA Non-Small Cell Lung Cancer AJCC v7; Stage IIIB Non-Small Cell Lung Cancer AJCC v7; Stage IV Non-Small Cell Lung Cancer AJCC v7; Stage IV Pleural Malignant Mesothelioma AJCC v7; WT1 Positive |
Fred Hutchinson Cancer Center |
2015-05-22 | PHASE1; PHASE2 |
| NCT02879513 | UNKNOWN | Invasive Ductal Breast Cancer; Tubular Breast Cancer; Mucinous Breast Cancer; Inflammatory Breast Cancer |
RenJi Hospital |
2014-01 | PHASE3 |
| NCT03395860 | UNKNOWN | Graft-versus-host-disease; Prophylaxis |
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine |
2017-05-30 | PHASE2 |
| NCT02790580 | UNKNOWN | Breast Cancer |
National University Hospital, Singapore |
2016-05 | PHASE2 |
| NCT03161054 | COMPLETED | Aggressive Non-Hodgkin Lymphoma |
Fondazione Italiana Linfomi - ETS |
2017-09-12 | PHASE2 |
| NCT01363128 | COMPLETED | Acute Lymphoblastic Leukemia; Adult Acute Lymphoblastic Leukemia in Complete Remission; Burkitt Leukemia; Burkitt Lymphoma; CD20 Positive; Childhood Acute Lymphoblastic Leukemia in Complete Remission; Lymphoblastic Lymphoma |
M.D. Anderson Cancer Center |
2011-07-12 | PHASE2 |
| NCT01967823 | COMPLETED | Melanoma; Meningioma; Breast Cancer; Non-Small Cell Lung Cancer; Hepatocellular Cancer |
National Cancer Institute (NCI) |
2013-10-24 | PHASE2 |
| NCT03733587 | COMPLETED | Solid Tumor |
Genexine, Inc. |
2018-10-17 | PHASE1 |
| NCT01356680 | COMPLETED | Hodgkin Lymphoma |
University of Cologne |
2012-01-13 | PHASE3 |
| NCT02987244 | UNKNOWN | T Cell Non-Hodgkin's Lymphoma |
Peking Union Medical College Hospital |
2016-03 | PHASE1; PHASE2 |
| NCT03399448 | TERMINATED | Multiple Myeloma; Melanoma; Synovial Sarcoma; Myxoid/Round Cell Liposarcoma |
University of Pennsylvania |
2018-09-05 | PHASE1 |
| NCT01313429 | TERMINATED | Sarcoma; Melanoma; Epithelial Malignancies; Pleural Malignancies |
National Cancer Institute (NCI) |
2011-03-04 | PHASE1 |
| NCT03201965 | COMPLETED | Amyloidosis |
Janssen Research & Development, LLC |
2017-10-05 | PHASE3 |
| NCT00902044 | ACTIVE_NOT_RECRUITING | Sarcoma |
Baylor College of Medicine |
2010-02-11 | PHASE1 |
| NCT02858804 | COMPLETED | Mantle Cell Lymphoma |
Institute of Hematology & Blood Diseases Hospital, China |
2016-01 | PHASE4 |
| NCT02456350 | UNKNOWN | Chronic Lymphocytic Leukemia; Acute Lymphocytic Leukemia; Lymphoma |
Shenzhen Second People's Hospital |
2015-04 | PHASE1 |
| NCT00058422 | COMPLETED | Lymphoma |
Memorial Sloan Kettering Cancer Center |
2003-02-10 | PHASE2 |
| NCT02901145 | UNKNOWN | Antibodies, Neoplasm |
Hadassah Medical Organization |
2016-11 | PHASE1; PHASE2 |
| NCT02449278 | UNKNOWN | Diffuse Large B-cell Lymphoma |
Wuhan University |
2015-10 | PHASE3 |
| NCT03093168 | UNKNOWN | Multiple Myeloma |
The Second Affiliated Hospital of Henan University of Traditional Chinese Medicine |
2017-02-15 | PHASE1 |
| NCT02439788 | WITHDRAWN | Neuroblastoma |
Baylor College of Medicine |
2017-08 | PHASE1 |
| NCT02192775 | COMPLETED | Multiple Myeloma |
University of Arkansas |
2015-03 | PHASE2 |
| NCT02280525 | COMPLETED | Leukemia |
M.D. Anderson Cancer Center |
2015-03-05 | PHASE1 |
| NCT03493854 | COMPLETED | Early Breast Cancer |
Hoffmann-La Roche |
2018-06-14 | PHASE3 |
| NCT00392327 | COMPLETED | Anaplastic Medulloblastoma; Medulloblastoma |
Children's Oncology Group |
2007-05-23 | PHASE3 |
| NCT03208556 | UNKNOWN | Relapsed or Refractory B-cell Lymphoma |
Peking University |
2017-06-21 | PHASE1 |
| NCT02879526 | UNKNOWN | Relapse/Refratory Peripheral T Cell Lymphoma |
The First Affiliated Hospital with Nanjing Medical University |
2016-08 | PHASE2 |
| NCT01889069 | COMPLETED | Lymphoma |
Hoffmann-La Roche |
2013-07-31 | PHASE3 |
| NCT03533101 | COMPLETED | Cytokine Release Syndrome; Stem Cell Transplant Complications |
Hospital Universitario Dr. Jose E. Gonzalez |
2018-05-25 | PHASE1; PHASE2 |
| NCT03029273 | UNKNOWN | Lung Cancer, Nonsmall Cell, Recurrent |
Guangzhou Institute of Respiratory Disease |
2017-03-21 | PHASE1 |
| NCT02256150 | COMPLETED | Lupus Nephritis |
Asahi Kasei Therapeutics Corporation |
2014-11 | PHASE3 |
| NCT02671708 | COMPLETED | Autologous Hematopoietic Stem Cell Transplantation; Acute Myeloid Leukemia; Conditioning |
Nanfang Hospital, Southern Medical University |
2016-01 | PHASE2; PHASE3 |
| NCT01570348 | TERMINATED | Crohn Disease |
Fred Hutchinson Cancer Center |
2012-07-17 | PHASE2 |
| NCT03063983 | UNKNOWN | Osteosarcoma |
Grupo de Apoio ao Adolescente e a Crianca com Cancer |
2017-01-02 | PHASE2 |
| NCT03167177 | WITHDRAWN | Melanoma |
ImmunityBio, Inc. |
2017-12 | PHASE1; PHASE2 |
| NCT03169777 | WITHDRAWN | Colorectal Cancer |
ImmunityBio, Inc. |
2018-08 | PHASE1; PHASE2 |
| NCT02444728 | TERMINATED | Thrombocytopenia |
Chinese SLE Treatment And Research Group |
2015-07 | PHASE3 |
| NCT01992653 | COMPLETED | Lymphoma, Non Hodgkin |
Genentech, Inc. |
2013-11-29 | PHASE1; PHASE2 |
| NCT01492673 | COMPLETED | Neuroblastoma; Sarcoma |
Memorial Sloan Kettering Cancer Center |
2011-12 | PHASE2 |
| NCT03574649 | WITHDRAWN | Non Small Cell Lung Cancer |
ImmunityBio, Inc. |
2018-06 | PHASE2 |
| NCT00278421 | COMPLETED | Lymphoma |
German High-Grade Non-Hodgkin's Lymphoma Study Group |
2005-11 | PHASE3 |
| NCT00115700 | COMPLETED | Follicular Lymphoma |
Trans Tasman Radiation Oncology Group |
2000-02 | PHASE3 |
| NCT00450814 | COMPLETED | Recurrent Plasma Cell Myeloma; Refractory Plasma Cell Myeloma |
Mayo Clinic |
2006-11-30 | PHASE1; PHASE2 |
| NCT02120157 | COMPLETED | Myeloablative Conditioning; HLA-mismatched Bone Marrow Transplantation; Graft Survival; Transplantation, Bone Marrow |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2015-07-02 | PHASE2 |
| NCT02622074 | COMPLETED | Triple Negative Breast Neoplasms |
Merck Sharp & Dohme LLC |
2016-01-27 | PHASE1 |
| NCT00562978 | COMPLETED | Lymphoma |
City of Hope Medical Center |
2000-05-16 | PHASE1; PHASE2 |
| NCT01503905 | UNKNOWN | Breast Cancer Nos Premenopausal |
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University |
2011-12 | |
| NCT03425656 | COMPLETED | Malignant Neoplasm of Breast |
AryoGen Pharmed Co. |
2016-07-09 | PHASE3 |
| NCT02685059 | COMPLETED | Breast Cancer |
GBG Forschungs GmbH |
2016-06 | PHASE2 |
| NCT01836289 | WITHDRAWN | Crohn's Disease; Crohn Disease |
Johns Hopkins University |
2015-03 | PHASE1; PHASE2 |
| NCT01610869 | COMPLETED | Ovarian Cancer; Fallopian Tube Cancer |
University College, London |
2014-08 | PHASE2 |
| NCT02145039 | TERMINATED | Acute Leukemias; Burkitt's Lymphoma; Chronic Myelogenous Leukemia |
Masonic Cancer Center, University of Minnesota |
2014-10 | |
| NCT01653717 | COMPLETED | Advanced Cancers; Leukemia |
M.D. Anderson Cancer Center |
2013-06-11 | PHASE1 |
| NCT02194374 | WITHDRAWN | Leukemia |
M.D. Anderson Cancer Center |
2015-01 | PHASE1 |
| NCT02199041 | TERMINATED | Hematological Malignancies |
St. Jude Children's Research Hospital |
2014-07-11 | PHASE2 |
| NCT02096588 | TERMINATED | Breast Cancer; Stage I Breast Cancer; Stage II Breast Cancer; Stage III Breast Cancer |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2014-05-20 | PHASE2 |
| NCT01445821 | TERMINATED | Scleroderma, Systemic |
Northwestern University |
2011-09-15 | PHASE3 |
| NCT01193842 | COMPLETED | AIDS-Related Plasmablastic Lymphoma; AIDS-Related Primary Effusion Lymphoma; Ann Arbor Stage I Diffuse Large B-Cell Lymphoma; Ann Arbor Stage I Grade 3 Follicular Lymphoma; Ann Arbor Stage II Diffuse Large B-Cell Lymphoma; Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma; Ann Arbor Stage II Grade 3 Non-Contiguous Follicular Lymphoma; Ann Arbor Stage III Diffuse Large B-Cell Lymphoma; Ann Arbor Stage III Grade 3 Follicular Lymphoma; Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma; Ann Arbor Stage IV Grade 3 Follicular Lymphoma; HIV Infection; Plasmablastic Lymphoma; Primary Effusion Lymphoma; Recurrent Diffuse Large B-Cell Lymphoma; Recurrent Grade 3 Follicular Lymphoma |
National Cancer Institute (NCI) |
2010-10-06 | PHASE1; PHASE2 |
| NCT00498316 | COMPLETED | Myelodysplastic Syndrome; Leukemia |
M.D. Anderson Cancer Center |
2007-07-03 | PHASE1 |
| NCT01749111 | TERMINATED | Acute Myelogenous Leukemia; Acute Lymphoid Leukemia; Myeloproliferative Disease; Myelodysplastic Syndrome; Chronic Myeloid Leukemia; Chronic Myelomonocytic Leukemia |
Hospital Israelita Albert Einstein |
2012-12 | PHASE3 |
| NCT01279902 | UNKNOWN | Diffuse Large B-cell Lymphoma |
Asan Medical Center |
2010-08 | PHASE2 |
| NCT01421017 | COMPLETED | Breast Cancer; Metastatic Breast Cancer; Recurrent Breast Cancer |
NYU Langone Health |
2011-08-19 | PHASE1; PHASE2 |
| NCT02489266 | WITHDRAWN | Metastatic Melanoma |
National Cancer Institute (NCI) |
2015-06-24 | PHASE1 |
| NCT01055314 | COMPLETED | Adult Rhabdomyosarcoma; Childhood Alveolar Rhabdomyosarcoma; Childhood Embryonal Rhabdomyosarcoma; Metastatic Childhood Soft Tissue Sarcoma; Stage IV Adult Soft Tissue Sarcoma; Untreated Childhood Rhabdomyosarcoma |
National Cancer Institute (NCI) |
2010-01 | PHASE2 |
| NCT00545714 | COMPLETED | Leukemia, Lymphocytic, Chronic, B-Cell |
Hoffmann-La Roche |
2007-11-21 | PHASE2 |
| NCT01271010 | TERMINATED | Lymphocytic Leukemia, Chronic |
Hoffmann-La Roche |
2011-06-17 | PHASE4 |
| NCT01216111 | COMPLETED | Triple Negative Breast Cancer |
Fudan University |
2011-01-01 | PHASE3 |
| NCT04031703 | COMPLETED | Breast Cancer |
Fudan University |
2011-01-01 | PHASE3 |
| NCT00381680 | COMPLETED | B-cell Childhood Acute Lymphoblastic Leukemia; L1 Childhood Acute Lymphoblastic Leukemia; L2 Childhood Acute Lymphoblastic Leukemia; Intermediate Risk Recurrent Childhood Acute Lymphoblastic Leukemia |
Children's Oncology Group |
2007-03 | PHASE3 |
| NCT01980589 | COMPLETED | Multiple Myeloma |
Amgen |
2013-08 | PHASE1 |
| NCT01332968 | COMPLETED | Non-Hodgkin's Lymphoma |
Hoffmann-La Roche |
2011-07-06 | PHASE3 |
| NCT01132807 | COMPLETED | Lymphoma |
Alliance for Clinical Trials in Oncology |
2010-05 | PHASE2 |
| NCT01839097 | COMPLETED | Peripheral T-cell Lymphoma |
Acrotech Biopharma Inc. |
2013-05 | PHASE1 |
| NCT00727415 | COMPLETED | Chronic Lymphocytic Leukemia |
Gruppo Italiano Malattie EMatologiche dell'Adulto |
2008-02 | PHASE1; PHASE2 |
| NCT01677949 | WITHDRAWN | Acute Myeloid Leukemia; Acute Lymphoblastic Leukemia |
Masonic Cancer Center, University of Minnesota |
2013-12 | PHASE2 |
| NCT01766375 | UNKNOWN | Acute Myeloid Leukemia |
Guangxi Medical University |
2012-08 | PHASE3 |
| NCT01729338 | TERMINATED | Multiple Myeloma |
Duke University |
2012-12-19 | PHASE2 |
| NCT00972478 | ACTIVE_NOT_RECRUITING | Ann Arbor Stage II Non-Hodgkin Lymphoma; Ann Arbor Stage III Non-Hodgkin Lymphoma; Ann Arbor Stage IV Non-Hodgkin Lymphoma |
National Cancer Institute (NCI) |
2010-11-15 | PHASE1; PHASE2 |
| NCT02794077 | COMPLETED | Recurrent Nasopharyngeal Undifferentiated Carcinoma; Stage IV Nasopharyngeal Undifferentiated Carcinoma |
The University of Hong Kong |
2008-01 | PHASE2 |
| NCT01093586 | COMPLETED | Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome; Adult Acute Lymphoblastic Leukemia in Remission; Adult Acute Megakaryoblastic Leukemia (M7); Adult Acute Minimally Differentiated Myeloid Leukemia (M0); Adult Acute Monoblastic Leukemia (M5a); Adult Acute Monocytic Leukemia (M5b); Adult Acute Myeloid Leukemia in Remission; Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Erythroleukemia (M6a); Adult Nasal Type Extranodal NK/T-cell Lymphoma; Adult Pure Erythroid Leukemia (M6b); B-cell Adult Acute Lymphoblastic Leukemia; B-cell Childhood Acute Lymphoblastic Leukemia; Blastic Phase Chronic Myelogenous Leukemia; Burkitt Lymphoma; Childhood Acute Erythroleukemia (M6); Childhood Acute Lymphoblastic Leukemia in Remission; Childhood Acute Megakaryocytic Leukemia (M7); Childhood Acute Minimally Differentiated Myeloid Leukemia (M0); Childhood Acute Monoblastic Leukemia (M5a); Childhood Acute Monocytic Leukemia (M5b); Childhood Acute Myeloid Leukemia in Remission; Childhood Chronic Myelogenous Leukemia; Childhood Diffuse Large Cell Lymphoma; Childhood Immunoblastic Large Cell Lymphoma; Childhood Myelodysplastic Syndromes; Childhood Nasal Type Extranodal NK/T-cell Lymphoma; Chronic Myelomonocytic Leukemia; Chronic Phase Chronic Myelogenous Leukemia; Cutaneous B-cell Non-Hodgkin Lymphoma; de Novo Myelodysplastic Syndromes; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Juvenile Myelomonocytic Leukemia; Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable; Nodal Marginal Zone B-cell Lymphoma; Previously Treated Myelodysplastic Syndromes; Prolymphocytic Leukemia; Recurrent Adult Acute Lymphoblastic Leukemia; Recurrent Adult Acute Myeloid Leukemia; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Grade III Lymphomatoid Granulomatosis; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Childhood Acute Lymphoblastic Leukemia; Recurrent Childhood Acute Myeloid Leukemia; Recurrent Childhood Anaplastic Large Cell Lymphoma; Recurrent Childhood Grade III Lymphomatoid Granulomatosis; Recurrent Childhood Large Cell Lymphoma; Recurrent Childhood Lymphoblastic Lymphoma; Recurrent Childhood Small Noncleaved Cell Lymphoma; Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Mycosis Fungoides/Sezary Syndrome; Recurrent Small Lymphocytic Lymphoma; Refractory Chronic Lymphocytic Leukemia; Relapsing Chronic Myelogenous Leukemia; Secondary Acute Myeloid Leukemia; Secondary Myelodysplastic Syndromes; Secondary Myelofibrosis; Splenic Marginal Zone Lymphoma; Stage I Chronic Lymphocytic Leukemia; Stage II Chronic Lymphocytic Leukemia; Stage III Chronic Lymphocytic Leukemia; Stage IV Chronic Lymphocytic Leukemia; T-cell Adult Acute Lymphoblastic Leukemia; T-cell Childhood Acute Lymphoblastic Leukemia; T-cell Large Granular Lymphocyte Leukemia; Waldenstrom Macroglobulinemia |
Case Comprehensive Cancer Center |
2007-09 | PHASE2 |
| NCT01022138 | TERMINATED | Breast Cancer |
Barbara Ann Karmanos Cancer Institute |
2010-03-08 | PHASE2 |
| NCT00634179 | COMPLETED | Lymphoma, B-Cell; Follicular Lymphoma |
Emory University |
2008-02 | PHASE1; PHASE2 |
| NCT01540110 | COMPLETED | Breast Cancer |
National Cancer Centre, Singapore |
2010-08-11 | PHASE2 |
| NCT01312376 | TERMINATED | Ovarian Carcinoma; Fallopian Tube Cancer; Primary Peritoneal Cancer |
Abramson Cancer Center at Penn Medicine |
2011-03 | PHASE1 |
| NCT00924326 | COMPLETED | Primary Mediastinal B-cell Lymphoma; Diffuse, Large B-cell Lymphoma; Diffuse Large B-Cell Lymphoma Transformed From Follicular Lymphoma; Mantle Cell |
National Cancer Institute (NCI) |
2009-02-17 | PHASE1; PHASE2 |
| NCT00931918 | COMPLETED | Non-Germinal B-Cell-like (GCB) Diffuse Large B-cell Lymphoma (DLBCL) |
Millennium Pharmaceuticals, Inc. |
2009-10 | PHASE2 |
| NCT01971658 | COMPLETED | Multiple Myeloma |
Nantes University Hospital |
2013-10 | PHASE3 |
| NCT00450801 | COMPLETED | Lymphoma |
University of Miami |
2004-04 | PHASE2 |
| NCT02054104 | TERMINATED | Thoracic Sarcomas; Thorasic Cancers; Cancers of Non-thoracic Origin With Metastases to the Lungs or Pleura; Sarcoma; Melanoma |
National Cancer Institute (NCI) |
2014-09-03 | PHASE1; PHASE2 |
| NCT01222715 | COMPLETED | Adult Rhabdomyosarcoma; Childhood Alveolar Rhabdomyosarcoma; Childhood Pleomorphic Rhabdomyosarcoma; Childhood Rhabdomyosarcoma With Mixed Embryonal and Alveolar Features; Previously Treated Childhood Rhabdomyosarcoma; Recurrent Adult Soft Tissue Sarcoma; Recurrent Childhood Rhabdomyosarcoma |
National Cancer Institute (NCI) |
2010-10 | PHASE2 |
| NCT02204241 | COMPLETED | Multiple Myeloma |
European Myeloma Network B.V. |
2014-06 | PHASE1; PHASE2 |
| NCT01498588 | TERMINATED | Breast Neoplasms; Breast Cancer; Breast Tumors; Cancer of the Breast; Neoplasms, Breast; Tumors, Breast |
Emory University |
2011-11 | PHASE2 |
| NCT02206503 | COMPLETED | Multiple Myeloma |
Fondazione EMN Italy Onlus |
2013-03 | PHASE2 |
| NCT01985841 | TERMINATED | Breast Cancer |
Hellenic Oncology Research Group |
2011-10 | PHASE2 |
| NCT01143545 | TERMINATED | Lung Cancer; Esophageal Cancer; Malignant Pleural Mesothelioma; Sarcoma; Thymic Carcinoma |
National Cancer Institute (NCI) |
2010-12-07 | PHASE1 |
| NCT01145976 | UNKNOWN | Aplastic Anemia |
Cooperative Study Group A for Hematology |
2010-03 | PHASE3 |
| NCT00203502 | COMPLETED | Breast Cancer |
University of Arkansas |
2005-09 | PHASE2 |
| NCT00354835 | COMPLETED | Adult Rhabdomyosarcoma; Childhood Alveolar Rhabdomyosarcoma; Childhood Botryoid-Type Embryonal Rhabdomyosarcoma; Childhood Embryonal Rhabdomyosarcoma; Localized Childhood Soft Tissue Sarcoma; Rhabdomyosarcoma; Sarcoma; Stage I Adult Soft Tissue Sarcoma AJCC v7; Stage II Adult Soft Tissue Sarcoma AJCC v7; Stage III Adult Soft Tissue Sarcoma AJCC v7 |
Children's Oncology Group |
2006-12-26 | PHASE3 |
| NCT01306032 | COMPLETED | Ovarian Cancer; Primary Peritoneal Cancer; Serous Carcinoma Cancer; Triple-Negative Breast Cancer; Fallopian Tube Cancer |
National Cancer Institute (NCI) |
2011-01-12 | PHASE2 |
| NCT00824265 | COMPLETED | Leukaemia, Lymphocytic, Chronic |
Novartis Pharmaceuticals |
2009-03-12 | PHASE3 |
| NCT01045460 | COMPLETED | Multiple Myeloma |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2010-01-15 | PHASE2 |
| NCT00021255 | COMPLETED | Breast Neoplasms |
Sanofi |
2001-04 | PHASE3 |
| NCT01444118 | TERMINATED | Carcinoma, Non-Small-Cell Lung |
Bioven Europe |
2011-11 | PHASE3 |
| NCT01493453 | TERMINATED | CD19 Positive Non-Hodgkin Lymphoma |
The Christie NHS Foundation Trust |
2008-03 | PHASE1 |
| NCT00448019 | COMPLETED | Chronic Lymphocytic Leukemia |
M.D. Anderson Cancer Center |
2007-02 | PHASE2 |
| NCT01606241 | COMPLETED | Recurrent Breast Carcinoma; Recurrent Fallopian Tube Carcinoma; Recurrent Ovarian Carcinoma; Recurrent Primary Peritoneal Carcinoma; Stage IIA Breast Cancer; Stage IIA Fallopian Tube Cancer; Stage IIA Ovarian Cancer; Stage IIB Breast Cancer; Stage IIB Fallopian Tube Cancer; Stage IIB Ovarian Cancer; Stage IIC Fallopian Tube Cancer; Stage IIC Ovarian Cancer; Stage IIIA Breast Cancer; Stage IIIA Fallopian Tube Cancer; Stage IIIA Ovarian Cancer; Stage IIIA Primary Peritoneal Cancer; Stage IIIB Breast Cancer; Stage IIIB Fallopian Tube Cancer; Stage IIIB Ovarian Cancer; Stage IIIB Primary Peritoneal Cancer; Stage IIIC Breast Cancer; Stage IIIC Fallopian Tube Cancer; Stage IIIC Ovarian Cancer; Stage IIIC Primary Peritoneal Cancer; Stage IV Fallopian Tube Cancer; Stage IV Ovarian Cancer; Stage IV Primary Peritoneal Cancer |
Mayo Clinic |
2012-07-24 | PHASE1 |
| NCT01370772 | COMPLETED | B-cell Chronic Lymphocytic Leukemia CLL |
French Innovative Leukemia Organisation |
2011-05 | PHASE2 |
| NCT00866307 | COMPLETED | Acute Lymphoblastic Leukemia; Adult B Acute Lymphoblastic Leukemia; Childhood B Acute Lymphoblastic Leukemia |
Children's Oncology Group |
2009-02-23 | PHASE1 |
| NCT01947062 | UNKNOWN | Lung Cancer; Squamous Cell Carcinoma of the Lung; Locally Advanced and Metastatic Squamous Cell Carcinoma of the Lung |
Swami Rama Cancer Hospital and Research Institute |
2013-10 | PHASE3 |
| NCT01067989 | TERMINATED | Chemotherapy; Breast Cancer, Metastatic |
HaEmek Medical Center, Israel |
2010-03 | PHASE2 |
| NCT00885326 | COMPLETED | Neuroblastoma |
New Approaches to Neuroblastoma Therapy Consortium |
2009-12 | PHASE1 |
| NCT00087178 | COMPLETED | Breast Cancer |
NSABP Foundation Inc |
2004-05 | PHASE3 |
| NCT01537861 | TERMINATED | Multiple Myeloma |
Washington University School of Medicine |
2012-06 | EARLY_PHASE1 |
| NCT01415765 | WITHDRAWN | Lymphoma, Diffuse Large-Cell B-cell; Diffuse, Large B-cell Lymphoma; Lymphoma, Diffuse Large-Cell; Large-Cell Lymphoma, Diffuse |
National Cancer Institute (NCI) |
2011-07-15 | PHASE1; PHASE2 |
| NCT00621452 | COMPLETED | B-cell Chronic Lymphocytic Leukemia; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Nodal Marginal Zone B-cell Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Small Lymphocytic Lymphoma; Refractory Chronic Lymphocytic Leukemia; Splenic Marginal Zone Lymphoma; Waldenström Macroglobulinemia |
Fred Hutchinson Cancer Center |
2007-08 | PHASE1 |
| NCT00103285 | COMPLETED | Acute Lymphoblastic Leukemia; Childhood B Acute Lymphoblastic Leukemia |
Children's Oncology Group |
2005-04-11 | PHASE3 |
| NCT01283776 | COMPLETED | Multiple Myeloma; Non-Hodgkin-Lymphoma; Hodgkin's Disease |
University of Cologne |
2011-03 | PHASE2 |
| NCT01857115 | COMPLETED | Multiple Myeloma |
European Myeloma Network B.V. |
2013-04 | PHASE1; PHASE2 |
| NCT00107380 | COMPLETED | Lymphoma |
SWOG Cancer Research Network |
2005-11 | PHASE2 |
| NCT01322776 | UNKNOWN | Mantle Cell Lymphoma Recurrent |
Sun Yat-sen University |
2011-03 | PHASE1; PHASE2 |
| NCT01849380 | UNKNOWN | Breast Neoplasms; Neoadjuvant Therapy |
Shandong University |
2013-06 | PHASE4 |
| NCT01880385 | UNKNOWN | Inflammatory Breast Cancer |
Association Tunisienne de lutte Contre le Cancer |
2011-03 | PHASE1 |
| NCT02467010 | COMPLETED | Multiple Myeloma |
University Medical Center Groningen |
2008-09 | PHASE2 |
| NCT00453388 | COMPLETED | Acute Myeloid Leukemia in Remission; de Novo Myelodysplastic Syndrome; Fanconi Anemia; Previously Treated Myelodysplastic Syndrome |
Fred Hutchinson Cancer Center |
2007-02 | PHASE2 |
| NCT01415336 | UNKNOWN | Breast Cancer |
Peking Union Medical College Hospital |
2010-03 | PHASE2; PHASE3 |
| NCT01005914 | TERMINATED | Leukemia |
OHSU Knight Cancer Institute |
2009-06 | PHASE2 |
| NCT01612247 | UNKNOWN | Breast Cancer |
University of Vermont |
2011-02 | |
| NCT01321775 | UNKNOWN | Breast Cancer |
Hospital Universitario Madrid Sanchinarro |
2009-08 | PHASE2 |
| NCT01300247 | COMPLETED | Lymphocytic Leukemia, Chronic |
Genentech, Inc. |
2011-05 | PHASE1 |
| NCT01542255 | TERMINATED | Metastatic Melanoma |
Dartmouth-Hitchcock Medical Center |
2010-06 | PHASE2 |
| NCT00603460 | WITHDRAWN | Ovarian Cancer; Primary Peritoneal Cancer |
University of Pennsylvania |
2012-01 | PHASE1; PHASE2 |
| NCT00911183 | COMPLETED | Lymphoma |
Institut Bergonié |
2008-12-02 | PHASE2 |
| NCT01025778 | COMPLETED | Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia |
Lund University Hospital |
2009-12 | PHASE2 |
| NCT01191957 | COMPLETED | Acute Myeloid Leukemia (AML) |
Gruppo Italiano Trapianto di Midollo Osseo |
2008-01 | PHASE3 |
| NCT01339663 | COMPLETED | Recurrent Melanoma; Stage IV Melanoma |
Fred Hutchinson Cancer Center |
2012-03 | PHASE1 |
| NCT00669890 | TERMINATED | Acute Myeloid Leukemia; Juvenile Myelomonocytic Leukemia; Myelodysplastic Syndrome |
New York Medical College |
2004-05 | PHASE1 |
| NCT01346787 | COMPLETED | Multiple Myeloma |
European Myeloma Network B.V. |
2011-07 | PHASE2 |
| NCT00882323 | UNKNOWN | Aplastic Anemia |
The Korean Society of Pediatric Hematology Oncology |
2008-11 | PHASE2 |
| NCT02013817 | COMPLETED | Lymphocytic Leukemia, Chronic |
Hoffmann-La Roche |
2005-10-11 | PHASE2 |
| NCT00666484 | COMPLETED | Lymphoma; Neurotoxicity |
University College, London |
2008-03 | PHASE2 |
| NCT00737685 | UNKNOWN | Anemia, Aplastic |
The Korean Society of Pediatric Hematology Oncology |
2006-01 | PHASE2 |
| NCT00963872 | TERMINATED | Leukemia; Lymphoma; Multiple Myeloma; Myelodysplastic Syndromes |
Masonic Cancer Center, University of Minnesota |
2010-03 | PHASE1; PHASE2 |
| NCT01445522 | COMPLETED | Neoplasms; Lymphoma |
National Cancer Institute (NCI) |
2008-12-03 | PHASE1 |
| NCT00869973 | TERMINATED | Emesis |
S. Maria Hospital, Terni |
2009-09 | PHASE3 |
| NCT00578344 | TERMINATED | Sickle Cell Disease; Hemoglobin SC |
Tami D. John |
2005-07 | |
| NCT01040871 | COMPLETED | Diffuse Large B-Cell Lymphoma |
Millennium Pharmaceuticals, Inc. |
2010-01 | PHASE2 |
| NCT00055679 | COMPLETED | Breast Cancer |
UNICANCER |
2002-08 | PHASE3 |
| NCT01135329 | TERMINATED | Lymphoma; Leukemia; Myelodysplastic Syndrome |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2010-08 | PHASE2 |
| NCT01181999 | UNKNOWN | Lymphoma, Large B-cell, Diffuse |
Chonnam National University Hospital |
2010-08 | PHASE2 |
| NCT00589563 | COMPLETED | Chronic Myeloproliferative Disorders; Graft Versus Host Disease; Infection; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms; Precancerous Condition; Secondary Myelofibrosis; Small Intestine Cancer |
City of Hope Medical Center |
2007-05 | PHASE2 |
| NCT01229605 | WITHDRAWN | Breast Cancer |
Tufts Medical Center |
2010-10 | PHASE2 |
| NCT00807196 | UNKNOWN | Non-Hodgkins Lymphoma |
Maisonneuve-Rosemont Hospital |
2008-09 | PHASE1; PHASE2 |
| NCT00073918 | COMPLETED | Anaplastic Large Cell Lymphoma; Cutaneous B-cell Non-Hodgkin Lymphoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Nodal Marginal Zone B-cell Lymphoma; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Splenic Marginal Zone Lymphoma; Waldenström Macroglobulinemia |
Fred Hutchinson Cancer Center |
1999-02 | PHASE2 |
| NCT01329640 | TERMINATED | Locally Advanced HER2-positive Breast Cancer |
Instituto do Cancer do Estado de São Paulo |
2010-09 | PHASE2 |
| NCT00054327 | COMPLETED | Leukemia; Lymphoma; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases |
Case Comprehensive Cancer Center |
2000-11 | PHASE2 |
| NCT00006721 | COMPLETED | Lymphoma |
SWOG Cancer Research Network |
2001-03 | PHASE3 |
| NCT00939653 | TERMINATED | Relapsed Acute Myelogenous Leukemia |
Therapeutic Advances in Childhood Leukemia Consortium |
2009-07-10 | PHASE2 |
| NCT00125606 | TERMINATED | Acute Myeloid Leukemia |
University Hospital Muenster |
2004-10 | PHASE3 |
| NCT00048893 | TERMINATED | Breast Neoplasms; Metastases, Neoplasm |
National Cancer Institute (NCI) |
2002-11 | PHASE1; PHASE2 |
| NCT00228358 | COMPLETED | HER2-positive Breast Cancer; Recurrent Breast Cancer; Recurrent Non-small Cell Lung Cancer; Recurrent Ovarian Epithelial Cancer; Recurrent Ovarian Germ Cell Tumor; Stage IV Breast Cancer; Stage IV Non-small Cell Lung Cancer; Stage IV Ovarian Epithelial Cancer; Stage IV Ovarian Germ Cell Tumor |
University of Washington |
2003-06 | PHASE1 |
| NCT00876616 | COMPLETED | Lupus Nephritis |
Zhi-Hong Liu, M.D. |
2009-04 | |
| NCT00562965 | TERMINATED | Lymphoma, Follicular |
Pfizer |
2007-11 | PHASE3 |
| NCT00477035 | COMPLETED | Leukemia; Multiple Myeloma |
Sally Arai |
2006-05 | PHASE1 |
| NCT00256243 | COMPLETED | Breast Cancer |
Rita Sanghvi, Mehta |
2004-04 | PHASE2 |
| NCT00054236 | COMPLETED | Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases |
Case Comprehensive Cancer Center |
2002-05 | PHASE1 |
| NCT00088881 | TERMINATED | Contiguous Stage II Adult Diffuse Large Cell Lymphoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Nodal Marginal Zone B-cell Lymphoma; Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma; Splenic Marginal Zone Lymphoma; Stage I Adult Diffuse Large Cell Lymphoma; Testicular Lymphoma; Waldenström Macroglobulinemia |
National Cancer Institute (NCI) |
2004-12 | PHASE2 |
| NCT00194753 | COMPLETED | Breast Neoplasm |
University of Washington |
2001-12 | PHASE2 |
| NCT00303667 | COMPLETED | Acute Myelogenous Leukemia |
Masonic Cancer Center, University of Minnesota |
2005-01 | PHASE1; PHASE2 |
| NCT01001780 | WITHDRAWN | Active Chronic Graft Versus Host Disease |
University of Rochester |
2009-08 | PHASE2 |
| NCT00392886 | UNKNOWN | Brain and Central Nervous System Tumors |
Children's Hospital Los Angeles |
2004-03 | PHASE3 |
| NCT00354419 | TERMINATED | Aplastic Anemia |
Fred Hutchinson Cancer Center |
2006-02 | PHASE1 |
| NCT00079105 | COMPLETED | Lymphoma |
Newcastle-upon-Tyne Hospitals NHS Trust |
2004-01 | PHASE2 |
| NCT00477945 | COMPLETED | Non Hodgkin's Lymphoma |
Indiana University |
2007-05 | PHASE1 |
| NCT00334672 | UNKNOWN | Nonneoplastic Condition |
Children's Cancer and Leukaemia Group |
2006-03 | PHASE3 |
| NCT00924001 | TERMINATED | Melanoma; Malignant Melanoma; Melanoma, Experimental |
National Cancer Institute (NCI) |
2007-08 | PHASE1; PHASE2 |
| NCT00801580 | UNKNOWN | Lymphoid Leukemia |
University of Bologna |
2008-03 | PHASE2 |
| NCT00550771 | COMPLETED | Breast Neoplasm |
Merck Sharp & Dohme LLC |
2007-07-16 | PHASE2 |
| NCT00787761 | COMPLETED | Myeloproliferative Disorders; Kidney Cancer; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases |
Northside Hospital, Inc. |
2007-04 | PHASE2 |
| NCT00176904 | COMPLETED | Adrenoleukodystrophy; Metachromatic Leukodystrophy; Globoid Cell Leukodystrophy; Gaucher's Disease; Fucosidosis; Wolman Disease; Niemann-Pick Disease; Batten Disease; GM1 Gangliosidosis; Tay Sachs Disease; Sandhoff Disease |
Masonic Cancer Center, University of Minnesota |
1995-01 | PHASE2; PHASE3 |
| NCT00241254 | COMPLETED | Multiple Sclerosis, Chronic Progressive |
University Hospital, Bordeaux |
2005-12 | PHASE3 |
| NCT00134017 | COMPLETED | Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2004-06 | PHASE2 |
| NCT01869192 | COMPLETED | Malignant Neoplasm of Female Breast |
University of Colorado, Denver |
2003-03-05 | PHASE2 |
| NCT00464646 | COMPLETED | Breast Cancer |
NSABP Foundation Inc |
2007-05 | PHASE2 |
| NCT00533936 | UNKNOWN | Breast Cancer |
Instituto Nacional de Cancerologia, Columbia |
2006-09 | PHASE2 |
| NCT00455533 | COMPLETED | Breast Cancer |
Bristol-Myers Squibb |
2007-10 | PHASE2 |
| NCT00547196 | COMPLETED | Leukemia; Lymphoma; Myelodysplastic Syndromes |
City of Hope Medical Center |
2005-08-16 | |
| NCT00774280 | COMPLETED | Leukemia; Myelodysplastic Syndrome |
Cooperative Study Group A for Hematology |
2002-05 | PHASE3 |
| NCT00704938 | TERMINATED | Kidney Cancer; Melanoma (Skin); Unspecified Adult Solid Tumor, Protocol Specific |
National Institutes of Health Clinical Center (CC) |
2008-06 | PHASE2 |
| NCT00999986 | COMPLETED | Genital Wart |
Huazhong University of Science and Technology |
2007-01 | PHASE3 |
| NCT00407888 | COMPLETED | Estrogen Receptor-positive Breast Cancer; HER2-positive Breast Cancer; Stage IA Breast Cancer; Stage IB Breast Cancer; Stage II Breast Cancer; Stage IIIA Breast Cancer; Stage IIIB Breast Cancer; Stage IIIC Breast Cancer; Stage IV Breast Cancer |
University of Washington |
2006-05 | PHASE2 |
| NCT00562068 | UNKNOWN | Lymphoma; Small Intestine Cancer |
Cancer Research UK |
2007-05 | PHASE1 |
| NCT00494780 | COMPLETED | Lymphoma, Follicular |
GlaxoSmithKline |
2007-06 | PHASE2 |
| NCT00349778 | COMPLETED | Multiple Myeloma |
Stanford University |
2006-08 | PHASE2 |
| NCT00096382 | COMPLETED | Melanoma (Skin) |
National Institutes of Health Clinical Center (CC) |
2004-09 | PHASE2 |
| NCT00301821 | COMPLETED | Lymphoma |
Alliance for Clinical Trials in Oncology |
2006-01 | PHASE2 |
| NCT00093834 | COMPLETED | Breast Cancer |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2004-01 | PHASE1 |
| NCT00136084 | COMPLETED | Leukemia, Myelocytic, Acute |
St. Jude Children's Research Hospital |
2002-08 | PHASE3 |
| NCT00135954 | COMPLETED | Glomerulonephritis, Membranous |
Radboud University Medical Center |
1997-07 | PHASE3 |
| NCT00072280 | TERMINATED | Sarcoma |
Children's Oncology Group |
2004-11 | PHASE2 |
| NCT00429026 | TERMINATED | Renal Cell Cancer |
M.D. Anderson Cancer Center |
2004-01 | PHASE2 |
| NCT00365417 | COMPLETED | Breast Cancer |
NSABP Foundation Inc |
2006-08 | PHASE2 |
| NCT00544765 | COMPLETED | Breast Cancer |
GBG Forschungs GmbH |
2002-09 | PHASE3 |
| NCT00004128 | UNKNOWN | Leukemia |
European Organisation for Research and Treatment of Cancer - EORTC |
1999-09 | PHASE3 |
| NCT00337987 | COMPLETED | Peripheral T-Cell Lymphoma |
Yale University |
2005-11 | PHASE2 |
| NCT00245115 | TERMINATED | Leukemia |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
2005-10 | PHASE1 |
| NCT00041132 | COMPLETED | Lymphoma |
SWOG Cancer Research Network |
2002-09 | PHASE2 |
| NCT00004188 | COMPLETED | Neuroblastoma |
Children's Oncology Group |
2001-02 | PHASE3 |
| NCT01341262 | COMPLETED | Multiple Myeloma |
IRCCS Azienda Ospedaliero-Universitaria di Bologna |
2002-03 | PHASE2 |
| NCT00003573 | COMPLETED | Brain Tumors; Central Nervous System Tumors |
Children's Oncology Group |
1998-11 | PHASE2 |
| NCT00275054 | COMPLETED | Chronic Lymphocytic Leukemia |
German CLL Study Group |
2005-10 | PHASE3 |
| NCT00239343 | COMPLETED | Breast Cancer |
AstraZeneca |
2004-10 | PHASE2 |
| NCT00004125 | COMPLETED | Breast Cancer |
Eastern Cooperative Oncology Group |
1999-11-16 | PHASE3 |
| NCT00146562 | COMPLETED | Breast Cancer; Stage I Breast Cancer; Stage II Breast Cancer |
Harold J. Burstein, MD, PhD |
2003-07 | PHASE2 |
| NCT00002542 | COMPLETED | Breast Cancer |
NCIC Clinical Trials Group |
1993-07-20 | PHASE3 |
| NCT00003638 | COMPLETED | Breast Cancer |
Oncothyreon Canada Inc. |
1999-01 | PHASE3 |
| NCT00053768 | COMPLETED | Lymphoma |
German High-Grade Non-Hodgkin's Lymphoma Study Group |
2002-04 | PHASE3 |
| NCT00020943 | COMPLETED | Lymphoma |
Alliance for Clinical Trials in Oncology |
2001-06 | PHASE2 |
| NCT00041327 | COMPLETED | Lymphoma |
AIDS Malignancy Consortium |
2002-10 | PHASE2 |
| NCT00077116 | COMPLETED | Leukemia; Myelodysplastic Syndromes |
European Organisation for Research and Treatment of Cancer - EORTC |
2003-11 | PHASE2 |
| NCT00003116 | COMPLETED | Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases |
Case Comprehensive Cancer Center |
1997-05 | PHASE2 |
| NCT00039481 | COMPLETED | Cardiac Toxicity; Unspecified Childhood Solid Tumor, Protocol Specific |
National Cancer Institute (NCI) |
2002-11 | PHASE1 |
| NCT00005596 | COMPLETED | Leukemia |
Children's Oncology Group |
2000-04 | PHASE3 |
| NCT00005090 | TERMINATED | Lymphoma |
SWOG Cancer Research Network |
2000-04 | PHASE3 |
| NCT00003727 | COMPLETED | Leukemia |
University of Maryland, Baltimore |
1999-03 | PHASE2 |
| NCT00003868 | COMPLETED | Leukemia |
Fred Hutchinson Cancer Center |
1999-02 | PHASE2 |
| NCT00007813 | COMPLETED | Brain and Central Nervous System Tumors; Childhood Germ Cell Tumor; Extragonadal Germ Cell Tumor; Liver Cancer; Neuroblastoma; Ovarian Cancer; Sarcoma; Testicular Germ Cell Tumor |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
1997-05-31 | PHASE1 |
| NCT00002700 | COMPLETED | Leukemia; Lymphoma |
European Organisation for Research and Treatment of Cancer - EORTC |
1995-08 | PHASE3 |
| NCT00002718 | COMPLETED | Leukemia; Lymphoma; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms |
Memorial Sloan Kettering Cancer Center |
1995-11 | PHASE2 |
| NCT00009997 | COMPLETED | Breast Cancer |
NYU Langone Health |
1999-03 | PHASE1 |
| NCT00002809 | COMPLETED | Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases |
Temple University |
1996-08 | PHASE2 |
| NCT00040469 | TERMINATED | Sickle Cell Anemia; Hemoglobinopathy; Thalassemia |
Baylor College of Medicine |
2000-08 | PHASE2 |
| NCT00004145 | COMPLETED | Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes |
University of Chicago |
1998-11 | PHASE2 |
| NCT00002943 | COMPLETED | Extragonadal Germ Cell Tumor; Ovarian Cancer; Testicular Germ Cell Tumor; Unspecified Adult Solid Tumor, Protocol Specific |
Wake Forest University Health Sciences |
1993-02 | PHASE2 |
| NCT00002548 | COMPLETED | Multiple Myeloma |
SWOG Cancer Research Network |
1994-01 | PHASE3 |
| NCT00005987 | TERMINATED | Multiple Myeloma and Plasma Cell Neoplasm |
Masonic Cancer Center, University of Minnesota |
2000-08 | PHASE2 |
| NCT00199095 | COMPLETED | Adult Acute Lymphocytic Leukemia |
Goethe University |
1997-02 | PHASE4 |
| NCT00002941 | COMPLETED | Lymphoma |
Children's Oncology Group |
1998-04 | PHASE2 |
| NCT00005804 | COMPLETED | Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Precancerous/Nonmalignant Condition; Small Intestine Cancer |
Fred Hutchinson Cancer Center |
1999-10 | PHASE2 |
| NCT00003425 | COMPLETED | Breast Cancer; Leukemia; Lymphoma; Neuroblastoma; Ovarian Cancer; Sarcoma; Unspecified Adult Solid Tumor, Protocol Specific |
University of Kentucky |
1997-12 | PHASE1; PHASE2 |
| NCT00652691 | COMPLETED | Ovarian Cancer; Peritoneal Cavity Cancer |
Mayo Clinic |
1998-08 | PHASE1 |
| NCT00004908 | COMPLETED | Lymphoma |
Northwestern University |
1999-11 | PHASE2 |
| NCT00003032 | COMPLETED | Breast Cancer |
NCIC Clinical Trials Group |
1997-04-25 | PHASE3 |
| NCT00003340 | COMPLETED | Leukemia |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
1997-11 | PHASE2 |
| NCT01177371 | COMPLETED | Accelerated Phase Chronic Myelogenous Leukemia; Adult Acute Lymphoblastic Leukemia in Remission; Adult Acute Megakaryoblastic Leukemia (M7); Adult Acute Monoblastic Leukemia (M5a); Adult Acute Monocytic Leukemia (M5b); Adult Acute Myeloblastic Leukemia With Maturation (M2); Adult Acute Myeloblastic Leukemia Without Maturation (M1); Adult Acute Myeloid Leukemia in Remission; Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Del(5q); Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With T(15;17)(q22;q12); Adult Acute Myeloid Leukemia With T(16;16)(p13;q22); Adult Acute Myeloid Leukemia With T(8;21)(q22;q22); Adult Acute Myelomonocytic Leukemia (M4); Adult Acute Promyelocytic Leukemia (M3); Adult Erythroleukemia (M6a); Adult Nasal Type Extranodal NK/T-cell Lymphoma; Adult Pure Erythroid Leukemia (M6b); Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Burkitt Lymphoma; Childhood Acute Erythroleukemia (M6); Childhood Acute Lymphoblastic Leukemia in Remission; Childhood Acute Megakaryocytic Leukemia (M7); Childhood Acute Monoblastic Leukemia (M5a); Childhood Acute Monocytic Leukemia (M5b); Childhood Acute Myeloblastic Leukemia With Maturation (M2); Childhood Acute Myeloblastic Leukemia Without Maturation (M1); Childhood Acute Myeloid Leukemia in Remission; Childhood Acute Myelomonocytic Leukemia (M4); Childhood Acute Promyelocytic Leukemia (M3); Childhood Chronic Myelogenous Leukemia; Childhood Myelodysplastic Syndromes; Chronic Phase Chronic Myelogenous Leukemia; Cutaneous B-cell Non-Hodgkin Lymphoma; De Novo Myelodysplastic Syndromes; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Hepatosplenic T-cell Lymphoma; Intraocular Lymphoma; Nodal Marginal Zone B-cell Lymphoma; Peripheral T-Cell Lymphoma; Post-transplant Lymphoproliferative Disorder; Previously Treated Myelodysplastic Syndromes; Recurrent Adult Acute Lymphoblastic Leukemia; Recurrent Adult Acute Myeloid Leukemia; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Diffuse Mixed Cell Lymphoma; Recurrent Adult Diffuse Small Cleaved Cell Lymphoma; Recurrent Adult Grade III Lymphomatoid Granulomatosis; Recurrent Adult Hodgkin Lymphoma; Recurrent Adult Immunoblastic Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Adult Non-Hodgkin Lymphoma; Recurrent Adult T-cell Leukemia/Lymphoma; Recurrent Childhood Acute Lymphoblastic Leukemia; Recurrent Childhood Acute Myeloid Leukemia; Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Mycosis Fungoides/Sezary Syndrome; Recurrent Small Lymphocytic Lymphoma; Refractory Multiple Myeloma; Relapsing Chronic Myelogenous Leukemia; Secondary Myelodysplastic Syndromes; Small Intestine Lymphoma; Splenic Marginal Zone Lymphoma; Testicular Lymphoma; Waldenstrom Macroglobulinemia |
Case Comprehensive Cancer Center |
1988-03 | PHASE2 |
| NCT00003605 | WITHDRAWN | Lymphoma |
Hoag Memorial Hospital Presbyterian |
1998-05 | PHASE2 |
| NCT00199069 | COMPLETED | Adult Acute Lymphocytic Leukemia |
Goethe University |
1993-04 | PHASE4 |
| NCT00003974 | COMPLETED | Lung Cancer; Malignant Mesothelioma |
Roswell Park Cancer Institute |
1997-08 | PHASE1 |
| NCT00590785 | COMPLETED | High Risk; Breast Cancer; Positive Nodes; Cyclophosphamide; Doxorubicin |
National Cancer Institute (NCI) |
1996-08-13 | PHASE3 |
| NCT00201318 | COMPLETED | Non-Hodgkin's Lymphoma |
National Health Research Institutes, Taiwan |
2001-09 | PHASE2 |
| NCT00018954 | COMPLETED | Leukemia; Lymphoma |
National Institutes of Health Clinical Center (CC) |
1992-10 | PHASE2 |
| NCT00004255 | COMPLETED | Graft Versus Host Disease; Leukemia; Myelodysplastic Syndromes |
Chimeric Therapies |
2000-03 | PHASE2; PHASE3 |
| NCT00288002 | COMPLETED | Breast Cancer |
GBG Forschungs GmbH |
2005-01 | PHASE3 |
| NCT00525642 | UNKNOWN | Breast Neoplasms; Adjuvant; Chemotherapy |
Fudan University |
2003-06 | PHASE2; PHASE3 |
| NCT00080925 | COMPLETED | Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms |
National Institutes of Health Clinical Center (CC) |
2004-02 | PHASE1 |
| NCT00030719 | UNKNOWN | Neuroblastoma |
University of Leicester |
2001-12 | PHASE3 |
| NCT00004900 | COMPLETED | Breast Cancer |
Hackensack Meridian Health |
1999-10 | PHASE2 |
| NCT00070447 | COMPLETED | Lymphoma |
National Cancer Institute (NCI) |
2003-11 | PHASE2 |
| NCT00025623 | COMPLETED | Neuroblastoma |
European Infant Neuroblastoma Study Group - 1999 |
1999-07 | PHASE2 |
| NCT00669812 | UNKNOWN | Lymphoma; Small Intestine Cancer |
Cancer Research UK |
2008-02 | PHASE2 |
| NCT00417053 | UNKNOWN | Neuroblastoma |
Children's Cancer and Leukaemia Group |
PHASE3 | |
| NCT00002987 | UNKNOWN | Lymphoma |
Medical Research Council |
1997-01 | PHASE3 |
| NCT00365755 | COMPLETED | Neuroblastoma |
Children's Cancer and Leukaemia Group |
PHASE3 | |
| NCT00001676 | COMPLETED | Glomerulonephritis; Lupus Nephritis; Systemic Lupus Erythematosus |
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) |
1998-01 | PHASE1 |
| NCT00001630 | COMPLETED | Autoimmune Disease; Autoimmune Hemolytic Anemia; Thrombocytopenia |
National Heart, Lung, and Blood Institute (NHLBI) |
1997-07-21 | PHASE1 |
| NCT00003679 | UNKNOWN | Breast Cancer |
Scottish Cancer Therapy Network |
1998-11 | PHASE3 |
| NCT00062140 | COMPLETED | Leukemia; Lymphoma; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases |
Fred Hutchinson Cancer Center |
2003-04 | PHASE1 |
| NCT00336414 | WITHDRAWN | Systemic Lupus Erythematosus Nephritis |
Istituto Giannina Gaslini |
2006-06 | PHASE3 |
| NCT00016887 | UNKNOWN | Lymphoma |
German Low Grade Lymphoma Study Group |
2000-12 | PHASE3 |
| NCT00002701 | UNKNOWN | Leukemia |
European Organisation for Research and Treatment of Cancer - EORTC |
1995-10 | PHASE3 |
| NCT00003578 | UNKNOWN | Lymphoma |
Lymphoma Trials Office |
1993-01 | PHASE3 |
| NCT00115414 | COMPLETED | Breast Cancer; Fever; Neutropenia |
Amgen |
PHASE2 | |
| NCT00003243 | COMPLETED | Leukemia; Lymphoma; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins |
1998-01 | PHASE1 |
| NCT00025610 | COMPLETED | Neuroblastoma |
European Infant Neuroblastoma Study Group - 1999 |
1999-07 | PHASE2 |
| NCT00002582 | COMPLETED | Breast Cancer |
Institute of Cancer Research, United Kingdom |
1993-06 | PHASE3 |
| NCT00022945 | COMPLETED | Mantle Cell Lymphoma |
Corixa Corporation |
PHASE2 | |
| NCT00005854 | COMPLETED | Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes |
Fred Hutchinson Cancer Center |
1999-12 | PHASE2 |
| NCT00002580 | COMPLETED | Breast Cancer |
Scottish Cancer Therapy Network |
1993-06 | PHASE3 |
(data from https://clinicaltrials.gov, updated on 2026-07-22)
Check the
Cyclophosphamide Monohydrate
product page for in-depth specifications, including solubility, stock solutions, MOA, and working concentrations.
Mechanism and Biochemical Profile
Appendix RUO and cGMP Quality Standards
| Quality Dimension | RUO (Research Use Only) | cGMP (Current Good Manufacturing Practice) |
|---|---|---|
| Clinical Applicability | Prohibited in human clinical trials or medical diagnostics. | Mandatory for human clinical trials (Phase I–III) and therapies. |
| Regulatory Status | Non-regulated grade; exempt from drug manufacturing laws. | Legally enforced by health authorities (e.g., FDA, EMA, NMPA). |
| Facility Environment | Unclassified analytical or research laboratories. | Validated Cleanrooms (ISO Class 5–8) with continuous monitoring. |
| Quality Control | Basic purity and activity testing. | Rigorous safety release testing (Sterility, Endotoxin, Mycoplasma). |
| Process Validation | Basic equipment calibration; no process validation required. | Full qualification (IQ/OQ/PQ) and complete batch records. |
| Quality Assurance | Vendor self-declared without required formal QMS. | Mandatory QA/QC unit, Change Control, CAPA, and vendor audits. |
| Regulatory Impact | High risk of IND rejection if used as a critical raw material. | Required for IND/NDA filings, supported by Drug Master Files (DMF). |
Footnotes
Regulatory Note: Governed by FDA (21 CFR Parts 210/211/312), EMA (EudraLex Vol 4), ICH Guidelines (E6/Q7/Q9/Q10), and compendial standards (USP <71>/<85>/<1043>).
- Cyclophosphamide Monohydrate Solubility in DMSO
- Cyclophosphamide Monohydrate Stock Solution
- Cyclophosphamide Monohydrate Storage
- Cyclophosphamide Monohydrate Stability
- Cyclophosphamide Monohydrate Molecular Weight
- Cyclophosphamide Monohydrate SMILES
- Cyclophosphamide Monohydrate CAS Number
- Cyclophosphamide Monohydrate Chemical Structure (2D and 3D)
- Cyclophosphamide Monohydrate SDS｜MSDS
Note: Technical data last updated: Sep 1, 2026.